UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)


☒			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, ~~2022~~2023


☐			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number: 000-50976

HURON CONSULTING GROUP INC.

(Exact name of registrant as specified in its charter)


Delaware						01-0666114
(State or other jurisdiction of incorporation or organization)						(IRS Employer Identification Number)

550 West Van Buren Street

Chicago, Illinois

60607

(Address of principal executive offices)

(Zip Code)

(312) 583-8700

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.01 per share	HURN	NASDAQ Global Select Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”, and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer

☒

Accelerated Filer

☐

Non-accelerated Filer

☐

Smaller Reporting
Company

☐

Emerging Growth Company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

As of April ~~26, 2022, 21,261,900~~25, 2023, 19,211,704 shares of the registrant’s common stock, par value $0.01 per share, were outstanding.

Table of Contents


Huron Consulting Group Inc.

HURON CONSULTING GROUP INC.

INDEX

Table of Contents

PART I - FINANCIAL INFORMATION

ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS

HURON CONSULTING GROUP INC.

CONSOLIDATED BALANCE SHEETS

(In thousands, except share and per share amounts)

(Unaudited)


		March 31, 2022		December 31, 2021			March 31, 2023		December 31, 2022
Assets	Assets					Assets
Current assets:	Current assets:					Current assets:
Cash and cash equivalents	Cash and cash equivalents	$	9,748	$	20,781	Cash and cash equivalents	$	12,026	$	11,834
Receivables from clients, net of allowances of $7,125 and $8,827, respectively		116,527		122,316
Unbilled services, net of allowances of $2,673 and $2,637, respectively		125,791		91,285
Receivables from clients, net of allowances of $12,803 and $10,600, respectively						Receivables from clients, net of allowances of $12,803 and $10,600, respectively	147,037		147,852
Unbilled services, net of allowances of $5,937 and $3,850, respectively						Unbilled services, net of allowances of $5,937 and $3,850, respectively	173,454		141,781
Income tax receivable	Income tax receivable	4,997		8,071		Income tax receivable	275		960
Prepaid expenses and other current assets	Prepaid expenses and other current assets	17,134		15,229		Prepaid expenses and other current assets	28,718		26,057
Total current assets	Total current assets	274,197		257,682		Total current assets	361,510		328,484
Property and equipment, net	Property and equipment, net	26,836		31,004		Property and equipment, net	24,179		26,107
Deferred income taxes, net	Deferred income taxes, net	1,791		1,804		Deferred income taxes, net	1,410		1,554
Long-term investments	Long-term investments	95,930		72,584		Long-term investments	96,473		91,194
Operating lease right-of-use assets	Operating lease right-of-use assets	33,737		35,311		Operating lease right-of-use assets	28,692		30,304
Other non-current assets	Other non-current assets	69,764		68,191		Other non-current assets	80,154		73,039
Intangible assets, net	Intangible assets, net	31,089		31,894		Intangible assets, net	21,161		23,392
Goodwill	Goodwill	623,841		620,879		Goodwill	624,966		624,966
Total assets	Total assets	$	1,157,185	$	1,119,349	Total assets	$	1,238,545	$	1,199,040
Liabilities and stockholders’ equity	Liabilities and stockholders’ equity					Liabilities and stockholders’ equity
Current liabilities:	Current liabilities:					Current liabilities:
Accounts payable	Accounts payable	$	12,364	$	13,621	Accounts payable	$	9,556	$	14,254
Accrued expenses and other current liabilities	Accrued expenses and other current liabilities	19,470		22,519		Accrued expenses and other current liabilities	28,938		27,268
Accrued payroll and related benefits	Accrued payroll and related benefits	64,169		139,131		Accrued payroll and related benefits	78,354		171,723

Current maturities of long-term debt		—		559

Current maturities of operating lease liabilities	Current maturities of operating lease liabilities	10,213		10,142		Current maturities of operating lease liabilities	10,825		10,530
Deferred revenues	Deferred revenues	21,632		19,212		Deferred revenues	20,542		21,909
Total current liabilities	Total current liabilities	127,848		205,184		Total current liabilities	148,215		245,684
Non-current liabilities:	Non-current liabilities:					Non-current liabilities:
Deferred compensation and other liabilities	Deferred compensation and other liabilities	40,296		43,458		Deferred compensation and other liabilities	38,404		33,614

Long-term debt, net of current portion		335,000		232,221
Long-term debt						Long-term debt	447,000		290,000
Operating lease liabilities, net of current portion	Operating lease liabilities, net of current portion	51,756		54,313		Operating lease liabilities, net of current portion	43,393		45,556
Deferred income taxes, net	Deferred income taxes, net	20,003		12,273		Deferred income taxes, net	32,564		32,146
Total non-current liabilities	Total non-current liabilities	447,055		342,265		Total non-current liabilities	561,361		401,316
Commitments and contingencies	Commitments and contingencies	0		0		Commitments and contingencies
Stockholders’ equity	Stockholders’ equity					Stockholders’ equity
Common stock; $0.01 par value; 500,000,000 shares authorized; 23,976,090 and 24,364,814 shares issued, respectively		237		239
Treasury stock, at cost, 2,645,999 and 2,495,172 shares, respectively		(135,367)		(135,969)
Common stock; $0.01 par value; 500,000,000 shares authorized; 22,047,299 and 22,507,159 shares issued, respectively						Common stock; $0.01 par value; 500,000,000 shares authorized; 22,047,299 and 22,507,159 shares issued, respectively	220		223
Treasury stock, at cost, 2,842,144 and 2,711,712 shares, respectively						Treasury stock, at cost, 2,842,144 and 2,711,712 shares, respectively	(141,353)		(137,556)
Additional paid-in capital	Additional paid-in capital	395,103		413,794		Additional paid-in capital	284,420		318,706
Retained earnings	Retained earnings	303,848		276,996		Retained earnings	365,967		352,548
Accumulated other comprehensive income	Accumulated other comprehensive income	18,461		16,840		Accumulated other comprehensive income	19,715		18,119
Total stockholders’ equity	Total stockholders’ equity	582,282		571,900		Total stockholders’ equity	528,969		552,040
Total liabilities and stockholders’ equity	Total liabilities and stockholders’ equity	$	1,157,185	$	1,119,349	Total liabilities and stockholders’ equity	$	1,238,545	$	1,199,040

The accompanying notes are an integral part of the consolidated financial statements.

Table of Contents

HURON CONSULTING GROUP INC.

CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE INCOME (LOSS)

(In thousands, except per share amounts)

(Unaudited)


		Three Months Ended March 31,						Three Months Ended March 31,
			2022		2021				2023		2022
Revenues and reimbursable expenses:	Revenues and reimbursable expenses:						Revenues and reimbursable expenses:
Revenues	Revenues		$	260,049	$	203,213	Revenues		$	317,895	$	260,049
Reimbursable expenses	Reimbursable expenses		4,726		1,934		Reimbursable expenses		8,490		4,726
Total revenues and reimbursable expenses	Total revenues and reimbursable expenses		264,775		205,147		Total revenues and reimbursable expenses		326,385		264,775
Operating expenses:	Operating expenses:						Operating expenses:
Direct costs (exclusive of depreciation and amortization included below)	Direct costs (exclusive of depreciation and amortization included below)		187,247		148,115		Direct costs (exclusive of depreciation and amortization included below)		228,383		187,247
Reimbursable expenses	Reimbursable expenses		4,756		2,003		Reimbursable expenses		8,624		4,756
Selling, general and administrative expenses	Selling, general and administrative expenses		48,395		39,808		Selling, general and administrative expenses		62,289		48,395
Restructuring charges	Restructuring charges		1,555		628		Restructuring charges		2,284		1,555
Depreciation and amortization	Depreciation and amortization		6,864		6,353		Depreciation and amortization		6,374		6,864

Total operating expenses	Total operating expenses		248,817		196,907		Total operating expenses		307,954		248,817
Operating income	Operating income		15,958		8,240		Operating income		18,431		15,958
Other income (expense), net:	Other income (expense), net:						Other income (expense), net:
Interest expense, net of interest income	Interest expense, net of interest income		(2,196)		(1,719)		Interest expense, net of interest income		(4,303)		(2,196)
Other income, net	Other income, net		24,365		420		Other income, net		1,719		24,365
Total other income (expense), net	Total other income (expense), net		22,169		(1,299)		Total other income (expense), net		(2,584)		22,169
Income before taxes	Income before taxes		38,127		6,941		Income before taxes		15,847		38,127
Income tax expense	Income tax expense		11,275		1,536		Income tax expense		2,428		11,275

Net income	Net income		$	26,852	$	5,405	Net income		$	13,419	$	26,852

Earnings per share:	Earnings per share:						Earnings per share:
Net income per basic share	Net income per basic share		$	1.29	$	0.25	Net income per basic share		$	0.70	$	1.29

Net income per diluted share	Net income per diluted share		$	1.27	$	0.24	Net income per diluted share		$	0.68	$	1.27
Weighted average shares used in calculating earnings per share:	Weighted average shares used in calculating earnings per share:						Weighted average shares used in calculating earnings per share:
Basic	Basic		20,850		21,932		Basic		19,119		20,850
Diluted	Diluted		21,167		22,341		Diluted		19,699		21,167
Comprehensive income (loss):	Comprehensive income (loss):						Comprehensive income (loss):
Net income	Net income		$	26,852	$	5,405	Net income		$	13,419	$	26,852
Foreign currency translation adjustments, net of tax	Foreign currency translation adjustments, net of tax		(43)		400		Foreign currency translation adjustments, net of tax		52		(43)
Unrealized loss on investment, net of tax			(2,661)		(4,648)
Unrealized gain on cash flow hedging instruments, net of tax			4,325		1,429
Other comprehensive income (loss)			1,621		(2,819)
Unrealized gain (loss) on investment, net of tax							Unrealized gain (loss) on investment, net of tax		3,873		(2,661)
Unrealized gain (loss) on cash flow hedging instruments, net of tax							Unrealized gain (loss) on cash flow hedging instruments, net of tax		(2,329)		4,325
Other comprehensive income							Other comprehensive income		1,596		1,621
Comprehensive income	Comprehensive income		$	28,473	$	2,586	Comprehensive income		$	15,015	$	28,473

The accompanying notes are an integral part of the consolidated financial statements.

Table of Contents

HURON CONSULTING GROUP INC.

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(In thousands, except share amounts)

(Unaudited)

Common Stock Treasury Stock Additional
Paid-In
Capital Retained
Earnings Accumulated Other
Comprehensive
Income Stockholders’
Equity
Shares Amount Shares Amount
Balance at December 31, 2021 23,868,918 $ 239 (2,908,849) $ (135,969) $ 413,794 $ 276,996 $ 16,840 $ 571,900
Comprehensive income 26,852 1,621 28,473
Issuance of common stock in connection with:
Restricted stock awards, net of cancellations 277,629 3 130,240 7,486 (7,489) —
Exercise of stock options 16,805 — 647 647
Share-based compensation 12,051 12,051
Shares redeemed for employee tax withholdings (139,491) (6,884) (6,884)
Share repurchases (523,399) (5) (23,900) (23,905)
Balance at March 31, 2022 23,639,953 $ 237 (2,918,100) $ (135,367) $ 395,103 $ 303,848 $ 18,461 $ 582,282
Balance at December 31, 2020 24,560,855 $ 246 (2,812,896) $ (129,886) $ 454,512 $ 214,009 $ 13,061 551,942
Comprehensive income 5,405 (2,819) 2,586
Issuance of common stock in connection with:
Restricted stock awards, net of cancellations 376,731 4 90,100 3,778 (3,782) —
Exercise of stock options 6,631 — 174 174
Share-based compensation 7,988 7,988
Shares redeemed for employee tax withholdings (165,203) (8,503) (8,503)
Share repurchases (245,718) (3) (13,181) (13,184)
Balance at March 31, 2021 24,698,499 $ 247 (2,887,999) $ (134,611) $ 445,711 $ 219,414 $ 10,242 $ 541,003



	Common Stock			Treasury Stock			Additional Paid-In Capital		Retained Earnings		Accumulated Other Comprehensive Income		Stockholders’ Equity
	Shares	Amount		Shares	Amount
Balance at December 31, 2022	22,231,593	$	223	(2,953,147)	$	(137,556)	$	318,706	$	352,548	$	18,119	$	552,040
Comprehensive income									13,419		1,596		15,015
Issuance of common stock in connection with:
Restricted stock awards, net of cancellations	297,581	3		118,449	5,732		(5,735)						—
Exercise of stock options	14,145	—					627						627
Share-based compensation							15,089						15,089
Shares redeemed for employee tax withholdings				(135,420)	(9,529)								(9,529)

Share repurchases	(632,894)	(6)					(44,267)						(44,273)
Balance at March 31, 2023	21,910,425	$	220	(2,970,118)	$	(141,353)	$	284,420	$	365,967	$	19,715	$	528,969

Balance at December 31, 2021	23,868,918	$	239	(2,908,849)	$	(135,969)	$	413,794	$	276,996	$	16,840	$	571,900
Comprehensive income									26,852		1,621		28,473
Issuance of common stock in connection with:
Restricted stock awards, net of cancellations	277,629	3		130,240	7,486		(7,489)						—
Exercise of stock options	16,805	—					647						647
Share-based compensation							12,051						12,051
Shares redeemed for employee tax withholdings				(139,491)	(6,884)								(6,884)
Share repurchases	(523,399)	(5)					(23,900)						(23,905)
Balance at March 31, 2022	23,639,953	$	237	(2,918,100)	$	(135,367)	$	395,103	$	303,848	$	18,461	$	582,282

The accompanying notes are an integral part of the consolidated financial statements.

Table of Contents

HURON CONSULTING GROUP INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

Three Months Ended
March 31,
2022 2021
Cash flows from operating activities:
Net income $ 26,852 $ 5,405
Adjustments to reconcile net income to cash flows from operating activities:
Depreciation and amortization 6,864 6,567
Non-cash lease expense 1,640 1,693
Share-based compensation 7,935 5,625
Amortization of debt discount and issuance costs 198 198
Allowances for doubtful accounts 28 —
Deferred income taxes 7,129 —
Gain on sale of property and equipment, excluding transaction costs (1,067) —
Change in fair value of contingent consideration liabilities 12 42
Change in fair value of preferred stock investment (26,964) —
Changes in operating assets and liabilities, net of acquisitions and divestiture:
(Increase) decrease in receivables from clients, net 5,791 1,178
(Increase) decrease in unbilled services, net (35,239) (23,086)
(Increase) decrease in current income tax receivable / payable, net 3,266 573
(Increase) decrease in other assets 1,361 327
Increase (decrease) in accounts payable and other liabilities (7,044) 2,566
Increase (decrease) in accrued payroll and related benefits (70,689) (74,273)
Increase (decrease) in deferred revenues 828 (9,569)
Net cash used in operating activities (79,099) (82,754)
Cash flows from investing activities:
Purchases of property and equipment (3,924) (637)
Purchases of business, net of cash acquired (2,289) (6,000)
Capitalization of internally developed software costs (2,060) (1,400)
Proceeds from sale of property and equipment 4,750 —
Divestiture of business 207 —
Net cash used in investing activities (3,316) (8,037)
Cash flows from financing activities:
Proceeds from exercises of stock options 648 174
Shares redeemed for employee tax withholdings (6,884) (8,503)
Share repurchases (24,097) (11,454)
Proceeds from bank borrowings 150,000 89,000
Repayments of bank borrowings (47,780) (24,135)
Deferred payment on business acquisition (500) —
Net cash provided by financing activities 71,387 45,082
Effect of exchange rate changes on cash (5) 155
Net decrease in cash and cash equivalents (11,033) (45,554)
Cash and cash equivalents at beginning of the period 20,781 67,177
Cash and cash equivalents at end of the period $ 9,748 $ 21,623
Supplemental disclosure of cash flow information:
Non-cash investing and financing activities:
Property and equipment expenditures and capitalized software included in accounts payable, accrued expenses and accrued payroll and related benefits $ 2,682 $ 3,545
Operating lease right-of-use asset obtained in exchange for operating lease liability $ 102 $ —
Contingent consideration related to purchase of business $ 869 $ —
Share repurchases included in accounts payable $ — $ 1,729
Deferred payment on business acquisition $ — $ 1,000


	Three Months Ended March 31,
	2023		2022
Cash flows from operating activities:
Net income	$	13,419	$	26,852
Adjustments to reconcile net income to cash flows from operating activities:
Depreciation and amortization	6,407		6,864
Non-cash lease expense	1,644		1,640
Lease-related impairment charge	1,870		—

Share-based compensation	11,562		7,935
Amortization of debt discount and issuance costs	191		198

Allowances for doubtful accounts	3		28
Deferred income taxes	—		7,129
(Gain) loss on sale of property and equipment, excluding transaction costs	1		(1,067)

Change in fair value of contingent consideration liabilities	435		12
Change in fair value of preferred stock investment	—		(26,964)

Changes in operating assets and liabilities, net of acquisitions and divestiture:
(Increase) decrease in receivables from clients, net	827		5,791
(Increase) decrease in unbilled services, net	(31,669)		(35,239)
(Increase) decrease in current income tax receivable / payable, net	1,487		3,266
(Increase) decrease in other assets	(5,205)		1,361
Increase (decrease) in accounts payable and other liabilities	(1,881)		(7,044)
Increase (decrease) in accrued payroll and related benefits	(89,843)		(70,689)
Increase (decrease) in deferred revenues	(1,349)		828
Net cash used in operating activities	(92,101)		(79,099)
Cash flows from investing activities:
Purchases of property and equipment	(1,956)		(3,924)

Investment in life insurance policies	(1,833)		—

Purchases of businesses	38		(2,289)
Capitalization of internally developed software costs	(6,575)		(2,060)
Proceeds from note receivable	154		—
Proceeds from sale of property and equipment	—		4,750
Divestiture of business	—		207
Net cash used in investing activities	(10,172)		(3,316)
Cash flows from financing activities:
Proceeds from exercises of stock options	627		648
Shares redeemed for employee tax withholdings	(9,529)		(6,884)
Share repurchases	(45,133)		(24,097)
Proceeds from bank borrowings	201,000		150,000
Repayments of bank borrowings	(44,000)		(47,780)
Payments for debt issuance costs	(16)		—
Deferred payments on business acquisition	(500)		(500)
Net cash provided by financing activities	102,449		71,387
Effect of exchange rate changes on cash	16		(5)
Net increase (decrease) in cash and cash equivalents	192		(11,033)
Cash and cash equivalents at beginning of the period	11,834		20,781
Cash and cash equivalents at end of the period	$	12,026	$	9,748
Supplemental disclosure of cash flow information:
Non-cash investing and financing activities:
Property and equipment expenditures and capitalized software included in current liabilities	$	4,062	$	2,682
Operating lease right-of-use assets obtained in exchange for operating lease liabilities	$	748	$	102
Contingent consideration related to purchase of business	$	—	$	869

The accompanying notes are an integral part of the consolidated financial statements.

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

1. Description of Business

Huron is a global professional services firm that ~~collaborates~~partners with clients to ~~put possible into practice by creating sound~~develop growth strategies, ~~optimizing~~optimize operations ~~accelerating~~and accelerate digital transformation using an enterprise portfolio of technology, data and ~~empowering businesses and their people~~analytics solutions to empower clients to own their future. By collaborating with clients, embracing diverse perspectives, encouraging new ideas and challenging the status quo, we create sustainable results for the organizations we serve.

We provide our services and products and manage our business ~~under 3~~through three operating segments: Healthcare, Education and Commercial. See Note 1413 “Segment Information” for ~~a discussion of our 3 segments.~~

~~Effective January 1, 2022, we modified our operating model to expand and~~ more deeply integrate our industry expertise with our digital, strategic and financial advisory capabilities. The new operating model will strengthen Huron’s go-to-market strategy, drive efficiencies that support margin expansion, and position the company to accelerate growth.

To align with the new operating model, effective with reporting for periods beginning January 1, 2022, we began reporting under the following 3 industries, which are our reportable segments: Healthcare, Education and Commercial. The Commercial segment includes all industries outside of healthcare and education, including, but not limited to, financial services and energy and utilities. In the new reporting structure, each segment includes all revenue and costs associated with engagements delivered in the respective segments' industries. The new Healthcare and Education segments include some revenue and costs historically reported in the Business Advisory segment and the Healthcare segment includes some revenue and costs historically reported in the Education segment. We also provide revenue reporting across two principal capabilities: i) Consulting and Managed Services and ii) Digital. These changes create greater transparency for investors by improving visibility into the core drivers of our business.information.

2. Basis of Presentation and Significant Accounting Policies

The accompanying unaudited consolidated financial statements reflect the financial position, results of operations, and cash flows as of and for the three months ended March 31, ~~2022~~2023 and ~~2021.~~2022. These financial statements have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission ("SEC") for Quarterly Reports on Form 10-Q. Accordingly, these financial statements do not include all of the information and note disclosures required by accounting principles generally accepted in the United States of America ("GAAP") for annual financial statements. In the opinion of management, these financial statements reflect all adjustments of a normal, recurring nature necessary for the fair statement of our financial position, results of operations, and cash flows for the interim periods presented in conformity with GAAP. These financial statements should be read in conjunction with our consolidated financial statements and notes thereto for the year ended December 31, ~~2021~~2022 included in our Annual Report on Form 10-K. Our results for any interim period are not necessarily indicative of results for a full year or any other interim period.

In order to better align with industry standards, in the first quarter of 2022, we revised the presentation of our consolidated statement of operations and other comprehensive income (loss) to present depreciation and amortization expense inclusive of amortization of intangible assets and software development costs previously presented within total direct costs and reimbursable expenses. We also aggregated immaterial line items within selling, general and administrative expenses. The change in presentation has no effect on our consolidated results, and our historical consolidated statements of operations and other comprehensive income (loss) were revised for consistent presentation.

Preparation of our consolidated financial statements requires management to make estimates and assumptions that affect the amounts reported in our consolidated financial statements and related disclosures. The business and economic uncertainty resulting from the coronavirus (COVID-19) pandemic has made such estimates and assumptions more difficult to predict. Accordingly, actual results and outcomes could differ from those estimates.

~~Table of Contents~~

~~HURON CONSULTING GROUP INC.~~

~~NOTES TO CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Tabular amounts in thousands, except per share amounts)~~

~~(Unaudited)~~

3. ~~New Accounting Pronouncements~~

~~Not Yet Adopted~~

~~In March 2020, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2020-04,~~ ~~Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. In January 2021, the FASB clarified the scope of that guidance with the issuance of ASU 2021-01,~~ ~~Reference Rate Reform (Topic 848): Scope~~. Together, these ASUs provide optional expedients and exceptions for a limited period of time to ease the potential burden in accounting for, or recognizing the effects of, reference rate reform on financial reporting under GAAP. This standard is optional and may be applied by entities after March 12, 2020, but no later than December 31, 2022. Our senior secured credit facility and related interest rate swaps are indexed to LIBOR; as such, we are currently evaluating the potential impact this guidance will have on our consolidated financial statements.

4. Goodwill and Intangible Assets

The table below sets forth the changes in the carrying amount of goodwill by reportable segment for the three months ended March 31, ~~2022.~~2023.

Healthcare Education
Commercial(1)
Total
Balance as of December 31, 2021:
Goodwill $ 642,951 $ 121,570 $ 312,250 $ 1,076,771
Accumulated impairment losses (208,081) — (247,811) (455,892)
Goodwill, net as of December 31, 2021 434,870 121,570 64,439 620,879
Goodwill reallocation(1)
18,057 (1,417) (16,640) —
Goodwill recorded in connection with business acquisitions (2)(3)
162 2,082 718 2,962
Goodwill, net as of March 31, 2022 $ 453,089 $ 122,235 $ 48,517 $ 623,841

~~(1)~~The goodwill balance as of December 31, 2021 shown within the Commercial segment related to our Business Advisory segment prior to the modification of our operating model. Effective January 1, 2022, we reallocated a portion of the goodwill within our Business Advisory segment to our Healthcare and Education segments. The remaining goodwill was allocated to our new Commercial segment.

~~(2)~~On January 18, 2022, we completed the acquisition of AIMDATA, LLC ("AIMDATA"), an advisory and implementation consulting services firm focused on strategy, technology and business transformation. The results of operations of AIMDATA are included within our consolidated financial statements as of the acquisition date and allocated among our 3 operating industries, which are our reportable segments, based on the engagements delivered by the business. The acquisition of AIMDATA is not significant to our consolidated financial statements.

~~(3)~~In the first quarter of 2022, we finalized the measurement of assets acquired, including goodwill, and liabilities assumed in the acquisition of Whiteboard Communications Ltd. ("Whiteboard"), a student enrollment advisory firm that helps colleges and universities with recruitment initiatives and financial aid strategies that we acquired in December 2021. The results of operations of Whiteboard are included in our consolidated financial statements and results of operations of our Education segment from the date of acquisition.

~~First Quarter 2022 Goodwill Reallocation~~

Effective January 1, 2022, we modified our operating model to expand and more deeply integrate our industry expertise with our digital, strategic and financial advisory capabilities. To align with the new operating model, effective with reporting for periods beginning January 1, 2022, we began reporting under the following 3 industries, which are our reportable segments: Healthcare, Education and Commercial. The Commercial segment includes all industries outside of healthcare and education, including, but not limited to, financial services and energy and utilities. In the new reporting structure, each segment includes all revenue and costs associated with engagements delivered in the respective segments' industries. The new Healthcare and Education segments include some revenue and costs historically reported in the Business Advisory segment and the Healthcare segment includes some revenue and costs historically reported in the Education segment.

~~Table of Contents~~

~~HURON CONSULTING GROUP INC.~~

~~NOTES TO CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Tabular amounts in thousands, except per share amounts)~~

~~(Unaudited)~~

The 3 reportable segments of Healthcare, Education and Commercial are also our reporting units for goodwill impairment testing purposes. As a result of the reorganization, we reallocated the goodwill balances of our historical reporting units to our new reporting units based on the relative estimated fair values of each component of the historical reporting units to be allocated to the new reporting units. Additionally, we performed a goodwill impairment test on the goodwill balances of each of our reporting units as of January 1, 2022 by comparing the fair value of the reporting unit to its carrying value, including the reallocated goodwill. Based on the results of the goodwill impairment test, we determined the fair values of the Healthcare, Education, and Commercial reporting units exceeded their carrying values by 37%, 199%, and 105%, respectively. As such, we concluded that there was no indication of goodwill impairment for all 3 reporting units as of January 1, 2022.

We relied on the income approach to estimate the fair value of the reporting units for both the goodwill reallocation and the goodwill impairment test. The income approach utilized a discounted cash flow analysis, which involved estimating the expected after-tax cash flows that will be generated by each business and then discounting those cash flows to present value, reflecting the relevant risks associated with each reporting unit and the time value of money. This approach requires the use of significant estimates and assumptions, including forecasted revenue growth rates, forecasted EBITDA margins, and discount rates that reflect the risk inherent in the future cash flows. In estimating future cash flows, we relied on internally generated ten-year forecasts. Our forecasts are based on historical experience, current backlog, expected market demand, and other industry information.


	Healthcare		Education		Commercial		Total
Balance as of December 31, 2022:
Goodwill	$	644,238	$	123,652	$	312,968	$	1,080,858
Accumulated impairment losses	(190,024)		(1,417)		(264,451)		(455,892)
Goodwill, net as of December 31, 2022	$	454,214	$	122,235	$	48,517	$	624,966


Goodwill, net as of March 31, 2023	$	454,214	$	122,235	$	48,517	$	624,966

Intangible Assets

Intangible assets as of March 31, ~~2022~~2023 and December 31, ~~2021~~2022 consisted of the following:


			As of March 31, 2022				As of December 31, 2021						As of March 31, 2023				As of December 31, 2022
		Useful Life (in years)	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization			Useful Life (in years)	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization
Customer relationships	Customer relationships	3 to 13	$	77,763	$	55,340	$	75,908	$	53,421	Customer relationships	5 to 13	$	65,083	$	49,257	$	74,583	$	57,219
Technology and software											Technology and software	2 to 5	13,330		8,513		13,330		7,975
Trade names	Trade names	6	6,000		5,338		6,000		5,148		Trade names	6	6,000		6,000		6,000		5,907
Technology and software		2 to 5	13,330		6,199		13,330		5,607
Non-competition agreements	Non-competition agreements	2 to 5	920		153		2,020		1,347		Non-competition agreements	2 to 5	920		402		920		340
Customer contracts		1	260		154		260		101

Total	Total		$	98,273	$	67,184	$	97,518	$	65,624	Total		$	85,333	$	64,172	$	94,833	$	71,441

Identifiable intangible assets with finite lives are amortized over their estimated useful lives. Customer relationships ~~and customer contracts,~~ as well as certain trade names and technology and software, are amortized on an accelerated basis to correspond to the cash flows expected to be derived from the assets. All other intangible assets with finite lives are amortized on a straight-line basis.

Intangible asset amortization expense was $2.9 million and $2.4 million for the three months ended March 31, 2022 and 2021, respectively. The table below sets forth the estimated annual amortization expense for the intangible assets recorded as of March 31, 2022.

Year Ending December 31,
Estimated Amortization Expense(1)
2022 $ 11,198
2023 $ 7,904
2024 $ 4,514
2025 $ 3,386
2026 $ 2,435

~~Actual future amortization expense could differ from these estimated amounts as a result of future acquisitions, dispositions, and other factors.~~

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

5.Intangible asset amortization expense was $2.2 million and $2.9 million for the three months ended March 31, 2023 and 2022, respectively. The table below sets forth the estimated annual amortization expense for the intangible assets recorded as of March 31, 2023.


Year Ending December 31,	Estimated Amortization Expense
2023	$	8,122
2024	$	4,674
2025	$	3,503
2026	$	2,519
2027	$	1,773

Actual future amortization expense could differ from these estimated amounts as a result of future acquisitions, dispositions, and other factors.

4. Revenues

For the three months ended March 31, ~~2022~~2023 and ~~2021,~~2022, we recognized revenues of $317.9 million and $260.0 million, respectively. Of the $317.9 million recognized in the first quarter of 2023, we recognized revenues of $1.2 million from obligations satisfied, or partially satisfied, in prior periods, due to the release of allowances on receivables from clients and ~~$203.2~~unbilled services. During the first quarter of 2023, we also recognized a $2.5 million ~~respectively.~~decrease to revenues due to changes in the estimates of our variable consideration under performance-based billing arrangements. Of the $260.0 million recognized in the first quarter of 2022, we recognized revenues of $1.9 million from obligations satisfied, or partially satisfied, in prior periods, of which $1.0 million was primarily due to the release of allowances on receivables from clients and unbilled services, and $0.9 million was due to changes in the estimates of our variable consideration under performance-based billing arrangements. Of the $203.2 million recognized in the first quarter of 2021, we recognized revenues of $4.8 million from obligations satisfied, or partially satisfied, in prior periods, of which $2.5 million was primarily due to the release of allowances on receivables from clients and unbilled services, and $2.3 million was due to changes in the estimates of our variable consideration under performance-based billing arrangements.

As of March 31, ~~2022,~~2023, we had ~~$89.8~~$143.8 million of remaining performance obligations under engagements with original expected durations greater than one year. These remaining performance obligations exclude variable consideration which has been excluded from the total transaction price due to the constraint and performance obligations under time-and-expense engagements which are recognized in the amount invoiced. Of the ~~$89.8~~$143.8 million of performance obligations, we expect to recognize ~~approximately $35.6~~$61.9 million as revenue in ~~2022, $28.5~~2023, $33.5 million in ~~2023,~~2024, and the remaining ~~$25.7~~$48.4 million thereafter. Actual revenue recognition could differ from these amounts as a result of changes in the estimated timing of work to be performed, adjustments to estimated variable consideration in performance-based arrangements, or other factors.

Contract Assets and Liabilities

The payment terms and conditions in our customer contracts vary. Differences between the timing of billings and the recognition of revenue are recognized as either unbilled services or deferred revenues in the consolidated balance sheets.

Unbilled services include revenues recognized for services performed but not yet billed to clients. Services performed that we are not yet entitled to bill because certain events, such as the completion of the measurement period or client approval in performance-based engagements, must occur are recorded as contract assets and included within unbilled services, net. The contract asset balance as of March 31, ~~2022~~2023 and December 31, ~~2021~~2022 was ~~$33.1~~$45.1 million and ~~$23.7~~$50.2 million, respectively. The ~~$9.4~~$5.1 million ~~increase~~decrease primarily reflects timing differences between the completion of our performance obligations and the amounts billed or billable to clients in accordance with their contractual billing terms.

Client prepayments and retainers are classified as deferred revenues and recognized over future periods in accordance with the applicable engagement agreement and our revenue recognition accounting policy. Our deferred revenues balance as of March 31, ~~2022~~2023 and December 31, ~~2021,~~2022, was ~~$21.6~~$20.5 million and ~~$19.2~~$21.9 million, respectively. The ~~$2.4~~$1.4 million ~~increase~~decrease primarily reflects timing differences between client payments in accordance with their contract terms and the completion of our performance obligations. For the three months ended March 31, ~~2022, $13.1~~2023, $16.4 million of revenues recognized were included in the deferred ~~revenues~~revenue balance as of December 31, ~~2021.~~2022.

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

6.5. Earnings Per Share

Basic earnings per share excludes dilution and is computed by dividing net income by the weighted average number of common shares outstanding for the period, excluding unvested restricted common stock. Diluted earnings per share reflects the potential reduction in earnings per share that could occur if securities or other contracts to issue common stock were exercised or converted into common stock under the treasury stock method. Such securities or other contracts include unvested restricted stock awards, unvested restricted stock units, and outstanding common stock options, to the extent dilutive. In periods for which we report a net loss, diluted weighted average common shares outstanding excludes all potential common stock equivalents as their impact on diluted net loss per share would be anti-dilutive.

Earnings per share under the basic and diluted computations are as follows:


		Three Months Ended March 31,						Three Months Ended March 31,
			2022		2021				2023		2022
Net income	Net income		$	26,852	$	5,405	Net income		$	13,419	$	26,852

Weighted average common shares outstanding – basic	Weighted average common shares outstanding – basic		20,850		21,932		Weighted average common shares outstanding – basic		19,119		20,850
Weighted average common stock equivalents	Weighted average common stock equivalents		317		409		Weighted average common stock equivalents		580		317
Weighted average common shares outstanding – diluted	Weighted average common shares outstanding – diluted		21,167		22,341		Weighted average common shares outstanding – diluted		19,699		21,167

Net income per basic share	Net income per basic share		$	1.29	$	0.25	Net income per basic share		$	0.70	$	1.29
Net income per diluted share	Net income per diluted share		$	1.27	$	0.24	Net income per diluted share		$	0.68	$	1.27

The number of anti-dilutive securities excluded from the computation of the weighted average common stock equivalents presented above for the three months ended March 31, 2023 and 2022 ~~and 2021~~ were ~~0.4~~less than 0.1 million shares and ~~less than 0.1~~0.4 million shares, respectively, and related to unvested restricted stock and outstanding common stock options.

In November 2020, our board of directors authorized a share repurchase program permitting us to repurchase up to $50 million of our common stock through December 31, 2021. ~~During~~Subsequent to the ~~third quarter of 2021,~~initial authorization, our board of directors authorized ~~an extension~~extensions of the share repurchase program ~~through December 31, 2022 and increased the authorized amount to $100 million. During the first quarter of 2022, our board of directors authorized a further extension~~ through December 31, 2023 and increased the authorized amount to ~~$200~~$300 million. The amount and timing of repurchases under the share repurchase program were and will continue to be determined by management and depend on a variety of factors, including the trading price of our common stock, capacity under our credit facility, general market and business conditions, and applicable legal requirements. All shares repurchased and retired are reflected as a reduction to our basic weighted average shares outstanding based on the trade date of the share repurchase.

In the three months ended March 31, 2023, we repurchased and retired 632,894 shares for $44.3 million, and settled the repurchase of 15,200 shares for $1.1 million which were accrued as of December 31, 2022. In the three months ended March 31, 2022, we repurchased and retired 523,399 shares for $23.9 million, and settled the repurchase of 3,820 shares for $0.2 million that were accrued as of December 31, 2021. ~~In the three months ended March 31, 2021, we repurchased and retired 245,718 shares for $13.2 million, of which $1.7 million settled in the second quarter of 2021.~~ As of March 31, ~~2022, $106.3~~2023, $64.8 million remained available for share repurchases under our share repurchase program.

~~Table of Contents~~

~~HURON CONSULTING GROUP INC.~~

~~NOTES TO CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Tabular amounts in thousands, except per share amounts)~~

~~(Unaudited)~~

7.6. Financing Arrangements

~~A summary of the carrying amounts of our debt follows:~~
March 31,
2022 December 31,
2021
Senior secured credit facility $ 335,000 $ 230,000
Promissory note due 2024 — 2,780
Total long-term debt 335,000 232,780
Current maturities of long-term debt — (559)
Long-term debt, net of current portion $ 335,000 $ 232,221

~~Senior Secured Credit Facility~~

The Company has a $600 million five-year senior secured revolving credit facility, subject to the terms of a ~~Second~~Third Amended and Restated Credit Agreement dated as of ~~March 31, 2015, as amended to date (as amended and modified the~~November 15, 2022 (the "Amended Credit Agreement"), that becomes due and payable in full upon maturity on ~~September 27, 2024.~~November 15, 2027. The Amended Credit Agreement provides the option to increase the revolving credit facility or establish term loan facilities in an aggregate amount of up to ~~$150~~$250 million, subject to customary conditions and the approval of any lender whose commitment would be increased, resulting in a maximum available principal amount under the Amended Credit Agreement of ~~$750~~$850 million. The initial borrowings under the Amended Credit Agreement were used to refinance borrowings outstanding under a prior credit agreement, and future borrowings under the Amended Credit Agreement may be used for working capital, capital expenditures, ~~acquisitions of businesses,~~ share repurchases, permitted acquisitions, and other general corporate purposes.

Fees and interest on borrowings vary based on our Consolidated Leverage Ratio (as defined in the Amended Credit Agreement). At our option, borrowings under the Amended Credit Agreement will bear interest at one, ~~two,~~ three or ~~six-month LIBOR~~six month Term SOFR or an alternate base rate, in each case plus the applicable margin. The applicable margin will fluctuate between 1.125% per annum and 1.875% per annum, in the case of ~~LIBOR~~Term SOFR borrowings, or between 0.125% per annum and 0.875% per annum, in the case of base rate loans, based upon our Consolidated Leverage Ratio at such time.

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

In April 2023, the Company and PNC Capital Markets, LLC, as Sustainability Structuring Agent, with the consent of the Required Lenders (as defined in the Amended Credit Agreement), amended the Amended Credit Agreement to incorporate specified key performance indicators with respect to certain environmental, social and governance targets of the Company. Based upon the performance of the Company against those key performance indicators in each Reference Year (as defined in the First Amendment), certain adjustments to the otherwise applicable rates for interest, commitment fees and letter of credit fees will be made. These annual adjustments will not exceed an increase or decrease of 0.01% in the aggregate for all key performance indicators in the case of the commitment fee rate or an increase or decrease of 0.05% in the aggregate for all key performance indicators in the case of the Term SOFR borrowings, base rate borrowings or letter of credit fee rate.

Amounts borrowed under the Amended Credit Agreement may be prepaid at any time without premium or penalty. We are required to prepay the amounts outstanding under the Amended Credit Agreement in certain circumstances, including upon an Event of Default (as defined in the Amended Credit Agreement). In addition, we have the right to permanently reduce or terminate the unused portion of the commitments provided under the Amended Credit Agreement at any time.

The loans and obligations under the Amended Credit Agreement are secured pursuant to a ~~Second~~Third Amended and Restated Security Agreement and a ~~Second~~Third Amended and Restated Pledge Agreement (the “Pledge Agreement”) with Bank of America, N.A. as collateral agent, pursuant to which the Company and the subsidiary guarantors grant Bank of America, N.A., for the ratable benefit of the lenders under the Amended Credit Agreement, a first-priority lien, subject to permitted liens, on substantially all of the personal property assets of the Company and the subsidiary guarantors, and a pledge of 100% of the stock or other equity interests in all domestic subsidiaries and 65% of the stock or other equity interests in each “material first-tier foreign subsidiary” (as defined in the Pledge Agreement). entitled to vote and 100% of the stock or other equity interests in each material first-tier foreign subsidiary not entitled to vote.

The Amended Credit Agreement contains usual and customary representations and warranties; affirmative and negative covenants, which include limitations on liens, investments, additional indebtedness, and restricted payments; and two quarterly financial covenants as follows: (i) a maximum Consolidated Leverage Ratio (defined as the ratio of debt to consolidated EBITDA) of 3.75 to 1.00; however the maximum permitted Consolidated Leverage Ratio will increase to ~~4.00~~4.25 to 1.00 upon the occurrence of ~~certain transactions,~~a Qualified Acquisition (as defined in the Amended Credit Agreement), and (ii) a minimum Consolidated Interest Coverage Ratio (defined as the ratio of consolidated EBITDA to interest) of ~~3.50~~3.00 to 1.00. Consolidated EBITDA for purposes of the financial covenants is calculated on a continuing operations basis and includes adjustments to add back non-cash goodwill impairment charges, share-based compensation costs, certain non-cash restructuring charges, pro forma historical EBITDA for businesses acquired, and other specified items in accordance with the Amended Credit Agreement. For purposes of the Consolidated Leverage Ratio total debt is on a gross basis and is not netted against our cash balances. At March 31, ~~2022,~~2023, we were in compliance with these financial covenants with a Consolidated Leverage Ratio of ~~2.24~~2.75 to 1.00 and a Consolidated Interest Coverage Ratio of ~~19.08~~12.63 to 1.00.

Borrowings outstanding under the Amended Credit Agreement at March 31, ~~2022~~2023 totaled ~~$335.0 million.~~$447.0 million and are classified as long-term debt in our consolidated balance sheet. These borrowings carried a weighted average interest rate of ~~2.1%~~4.8%, including the effect of the interest rate swaps described in Note 98 “Derivative Instruments and Hedging Activity.” Borrowings outstanding under the Amended Credit Agreement at December 31, ~~2021~~2022 were ~~$230.0~~$290.0 million and carried a weighted average interest rate of ~~2.7%~~3.8%, including the effect of the interest rate ~~swaps.~~swaps in effect at that time. The borrowing capacity under the revolving credit facility is reduced by any outstanding borrowings under the revolving credit facility and outstanding letters of credit. At March 31, ~~2022,~~2023, we

~~Table of Contents~~

~~HURON CONSULTING GROUP INC.~~

~~NOTES TO CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Tabular amounts in thousands, except per share amounts)~~

~~(Unaudited)~~

had outstanding letters of credit totaling ~~$0.7~~$0.6 million, which are used as security deposits for our office facilities. As of March 31, ~~2022,~~2023, the unused borrowing capacity under the revolving credit facility was ~~$264.3~~$152.4 million.

~~Promissory Note due 2024~~

On June 30, 2017, in conjunction with our purchase of an aircraft related to the acquisition of Innosight, we assumed from the sellers of the aircraft a promissory note with an outstanding principal balance of $5.1 million. In the first quarter of 2022, we completed the sale of the aircraft to a third-party and used a portion of the sale proceeds to pay the remaining principal and unpaid interest on the promissory note. Prior to the repayment of the promissory note, the principal balance of the promissory note was subject to scheduled monthly principal payments until the maturity date of March 1, 2024. Under the terms of the promissory note, we paid interest on the outstanding principal amount at a rate of one month LIBOR plus 1.97% per annum. At December 31, 2021, the outstanding principal amount of the promissory note was $2.8 million, and the aircraft had a carrying amount of $3.7 million. As a result of the sale, we recognized a gain of $1.0 million and we no longer own any aircraft.

8.7. Restructuring Charges

Restructuring charges for the three months ended March 31, 2023 and 2022 were $2.3 million and $1.6 million, ~~compared to $0.6~~respectively. In the first quarter of 2023, we exited our office space in Hillsboro, Oregon which resulted in a $1.9 million non-cash impairment charge on the related fixed assets and right-of-use operating lease asset of that office space. Additionally, in the first quarter of 2023, we recognized $0.4 million of additional restructuring expense for ~~the three months ended March 31, 2021.~~rent and related expenses, net of sublease income, for previously vacated office spaces. The $1.6 million of restructuring charges ~~recognized~~incurred in the first ~~quarter~~three months of 2022 included $0.6 million offor rent and related expenses, net of sublease income, for previously vacated office spaces, $0.5 million of employee-related expenses, $0.3 million of accelerated amortization of capitalized software implementation costs for a cloud-computing arrangement that is no longer in use, and $0.1 million for third-party transaction expenses related to the modification of our operating model. ~~The $0.6 million~~

Table of ~~restructuring charges recognized~~Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in ~~the first quarter of 2021 primarily related to rent and related expenses, net of sublease income, and accelerated depreciation on furniture and fixtures for vacated office spaces.~~thousands, except per share amounts)

(Unaudited)

The table below sets forth the changes in the carrying amount of our restructuring charge liability by restructuring type for the three months ended March 31, ~~2022.~~2023.
Employee Costs Other Total
Balance as of December 31, 2021 $ 573 $ 567 $ 1,140
Additions 500 95 595
Payments (324) (121) (445)
Adjustments
7 — 7
Balance as of March 31, 2022 $ 756 $ 541 $ 1,297


	Employee Costs		Other		Total
Balance as of December 31, 2022	$	3,751	$	568	$	4,319

Payments	(2,966)		(33)		(2,999)

Balance as of March 31, 2023	$	785	$	535	$	1,320

All of the $0.8 million restructuring charge liability related to employee costs at March 31, ~~2022~~2023 is expected to be paid in the next 12 months and is included as a component of accrued payroll and related benefits in our consolidated balance sheet. All of the $0.5 million other restructuring charge liability at March 31, 2023, which relates to the early termination of a contract in 2022, is expected to be paid ~~over~~in the next 12 months and is included as a component of accrued expenses and other current liabilities in our consolidated balance sheet.

9.8. Derivative Instruments and Hedging Activity

~~On June 22, 2017,~~In the normal course of business, we ~~entered~~use forward interest rate swaps to manage the interest rate risk associated with our variable-rate borrowings under our senior secured credit facility and we use non-deliverable foreign exchange forward contracts to manage the foreign currency exchange rate risk related to our Indian Rupee-denominated expenses of our operations in India. From time to time, we may enter into aadditional forward interest rate swaps or non-deliverable foreign exchange forward contracts to further hedge against our interest rate risk and foreign currency exchange rate risk. We do not use derivative instruments for trading or other speculative purposes.

We have designated all of our derivative instruments as cash flow hedges. Therefore, changes in the fair value of the interest rate swaps and foreign exchange forward contracts are recorded to other comprehensive income (“OCI”) to the extent effective and reclassified to earnings upon settlement.

Interest Rate Swaps

We are party to forward interest rate swap ~~agreement effective August~~agreements with aggregate notional amounts of $250.0 million and $200.0 million as of March 31, ~~2017~~2023 and ~~ending August~~December 31, 2022, ~~with a notional amount of $50.0 million. We entered into this derivative instrument to hedge against the interest rate risks of our variable-rate borrowings.~~respectively. Under the terms of the interest rate swap ~~agreement,~~agreements, we receive from the counterparty interest on the notional amount based on one month ~~LIBOR~~Term SOFR and we pay to the counterparty a stated, fixed ~~rate of 1.900%.~~

~~On January 30, 2020, we entered into a~~rate. The forward interest rate swap ~~agreement effective~~agreements have staggered maturities through February 29, 2028.

As of March 31, 2023, it was anticipated that $5.1 million of the gains, net of tax, related to interest rate swaps currently recorded in accumulated other comprehensive income will be reclassified into interest expense, net of interest income in our consolidated statement of operations within the next 12 months.

Foreign Exchange Forward Contracts

We are party to non-deliverable foreign exchange forward contracts that are scheduled to mature monthly through December 29, 2023. As of March 31, 2023 and December 31, ~~2019~~2022, the aggregate notional amounts of these contracts were INR 789.6 million, or $9.6 million, and ~~ending December~~INR 657.9 million, or $8.0 million, respectively, based on the exchange rates in effect as of each period end.

As of March 31, ~~2024, with a notional amount of $50.0 million. We entered into this derivative instrument to further hedge against the interest rate risks of our variable-rate borrowings. Under the terms~~2023, it was anticipated that less than $0.1 million of the ~~interest rate swap agreement, we receive from~~gains, net of tax, related to foreign exchange forward contracts currently recorded in accumulated other comprehensive income will be reclassified into direct costs in our consolidated statement of operations within the ~~counterparty interest on the notional amount based on one month LIBOR and we pay to the counterparty a fixed rate of 1.500%.~~

On March 16, 2020, we entered into a forward interest rate swap agreement effective February 28, 2020 and ending February 28, 2025, with a notional amount of $100.0 million. We entered into this derivative instrument to further hedge against the interest rate risks of our variable-rate borrowings. Under the terms of the interest rate swap agreement, we receive from the counterparty interest on the notional amount based on one month LIBOR and we pay to the counterparty a fixed rate of 0.885%.next 12 months.

119

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

We recognize all derivative instruments as either assets or liabilities at fair value in the consolidated balance sheet. We have designated these derivative instruments as cash flow hedges. Therefore, changes in the fair value of the derivative instruments are recorded to other comprehensive income (“OCI”) to the extent effective and reclassified into interest expense, net of interest income upon settlement. As of March 31, 2022, it was anticipated that $0.6 million of the gains, net of tax, currently recorded in accumulated other comprehensive income will be reclassified into earnings within the next 12 months.

The table below sets forth additional information relating to ~~the interest rate swaps designated as a cash flow hedging instrument~~our derivative instruments as of March 31, ~~2022~~2023 and December 31, ~~2021.~~2022.
Fair Value (Derivative Asset and Liability)
Balance Sheet Location March 31,
2022 December 31,
2021
Prepaid expenses and other current assets $ 1,019 $ —
Other non-current assets $ 4,501 $ 1,210
Accrued expenses and other current liabilities $ 183 $ 1,604
Deferred compensation and other liabilities $ — $ 149


Derivative Instrument	Balance Sheet Location	March 31, 2023		December 31, 2022
Interest rate swaps	Prepaid expenses and other current assets	$	6,628	$	7,108
Interest rate swaps	Other non-current assets	3,220		5,131
Foreign exchange forward contracts	Prepaid expenses and other current assets	65		—
Total Assets		$	9,913	$	12,239


Interest rate swaps	Deferred compensation and other liabilities	$	948	$	—
Foreign exchange forward contracts	Accrued expenses and other current liabilities	19		120
Total Liabilities		$	967	$	120

All of our derivative instruments are transacted under the International Swaps and Derivatives Association (ISDA) master agreements. These agreements permit the net settlement of amounts owed in the event of default and certain other termination events. Although netting is permitted, it is our policy to record all derivative assets and liabilities on a gross basis in our consolidated balance sheet.

~~We do not use derivative instruments for trading or other speculative purposes.~~ Refer to Note 1110 “Other Comprehensive Income (Loss)” for additional information on our derivative instruments.

~~10.~~9. Fair Value of Financial Instruments

Certain of our assets and liabilities are measured at fair value. Fair value is defined as the price that would be received to sell an asset or the price that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a fair value hierarchy for inputs used in measuring fair value and requires companies to maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy consists of three levels based on the objectivity of the inputs as follows:


Level 1 Inputs						Quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.

Level 2 Inputs						Quoted prices in active markets for similar assets or liabilities; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.

Level 3 Inputs						Unobservable inputs for the asset or liability, and include situations in which there is little, if any, market activity for the asset or liability.

1210

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

The table below sets forth our fair value hierarchy for our financial assets and liabilities measured at fair value on a recurring basis as of March 31, ~~2022~~2023 and December 31, ~~2021.~~2022.


		Level 1		Level 2		Level 3		Total			Level 1		Level 2		Level 3		Total
March 31, 2022
March 31, 2023										March 31, 2023
Assets:	Assets:									Assets:
Interest rate swap		$	—	$	5,520	$	—	$	5,520
Interest rate swaps										Interest rate swaps	$	—	$	9,482	$	—	$	9,482
Convertible debt investment										Convertible debt investment	—		—		62,842		62,842
Foreign exchange forward contracts										Foreign exchange forward contracts	—		65		—		65
Deferred compensation assets										Deferred compensation assets	—		33,489		—		33,489
Total assets										Total assets	$	—	$	43,036	$	62,842	$	105,878
Liabilities:										Liabilities:
Interest rate swaps										Interest rate swaps	$	—	$	582	$	—	$	582
Foreign exchange forward contracts										Foreign exchange forward contracts	—		19		—		19
Contingent consideration for business acquisitions										Contingent consideration for business acquisitions	—		—		3,625		3,625
Total liabilities										Total liabilities	$	—	$	601	$	3,625	$	4,226
December 31, 2022										December 31, 2022
Assets:										Assets:
Interest rate swaps										Interest rate swaps	$	—	$	12,239	$	—	$	12,239
Convertible debt investment	Convertible debt investment	—		—		62,301		62,301		Convertible debt investment	—		—		57,563		57,563
Deferred compensation assets	Deferred compensation assets	—		36,913		—		36,913		Deferred compensation assets	—		29,875		—		29,875
Total assets	Total assets	$	—	$	42,433	$	62,301	$	104,734	Total assets	$	—	$	42,114	$	57,563	$	99,677
Liabilities:	Liabilities:									Liabilities:
Interest rate swaps		$	—	$	183	$	—	$	183
Foreign exchange forward contracts										Foreign exchange forward contracts	$	—	$	120	$	—	$	120
Contingent consideration for business acquisitions	Contingent consideration for business acquisitions	—		—		4,620		4,620		Contingent consideration for business acquisitions	—		—		3,190		3,190
Total liabilities	Total liabilities	$	—	$	183	$	4,620	$	4,803	Total liabilities	$	—	$	120	$	3,190	$	3,310
December 31, 2021
Assets:
Interest rate swap		$	—	$	627	$	—	$	627
Convertible debt investment		—		—		65,918		65,918
Deferred compensation assets		—		39,430		—		39,430
Total assets		$	—	$	40,057	$	65,918	$	105,975
Liabilities:
Interest rate swaps		$	—	$	1,170	$	—	$	1,170
Contingent consideration for business acquisition		—		—		3,743		3,743
Total liabilities		$	—	$	1,170	$	3,743	$	4,913

Interest rate swaps: The fair values of our interest rate swaps were derived using estimates to settle the interest rate swap agreements, which are based on the net present value of expected future cash flows on each leg of the swaps utilizing market-based inputs and a discount rate reflecting the risks involved. Refer to Note 98 “Derivative Instruments and Hedging Activity” for additional information on our interest rate swaps.

~~Convertible debt investment:~~Foreign exchange forward contracts Since 2014, we have invested $40.9 million in the form of 1.69% convertible debt in Shorelight Holdings, LLC (“Shorelight”), the parent company of Shorelight, a U.S.-based company that partners with leading nonprofit universities to increase access to and retention of international students, boost institutional growth, and enhance an institution’s global footprint.: The ~~convertible notes will mature on January 17, 2024, unless converted earlier.~~

To determine the appropriate accounting treatment for our investment, we performed a variable interest entity (“VIE”) analysis and concluded that Shorelight does not meet the definition of a VIE. We also reviewed the characteristicsfair values of our ~~investment~~foreign exchange forward contracts were derived using estimates to ~~confirm that~~settle the ~~convertible notes~~foreign exchange forward contracts agreements, which are not in-substance common stock that would warrant equity method accounting. After we reviewed all of the terms of the investment, we concluded the appropriate accounting treatment to be that of an available-for-sale debt security.

The investment is carried at fair value with unrealized holding gains and losses excluded from earnings and reported in other comprehensive income. We estimate the fair value of our investment using a scenario-based approach in the form of a hybrid analysis that consists of a Monte Carlo simulation model and an expected return analysis. The conclusion of value for our investment is based on the probability-weighted assessment of both scenarios. The hybrid analysis utilizes certain assumptions including the assumed holding period through the maturity date of January 17, 2024; the applicable waterfall distribution at the end of the expected holding period based on the rights and privileges of the various instruments; cash flow projections discounted at the risk-adjusted rate of 22.5% as of both March 31, 2022 and December 31, 2021; and the concluded equity volatility of 40.0% and 45.0% as of March 31, 2022 and December 31, 2021, respectively, all of which are Level 3 inputs. The use of alternative estimates and assumptions could increase or decrease the estimated fairnet present value of expected future cash flows on each contract utilizing market-based inputs, including both forward and spot prices, and a discount rate reflecting the ~~investment, which would result in different impacts~~risks involved. Refer to Note 8 “Derivative Instruments and Hedging Activity” for additional information on our consolidated balance sheet and comprehensive income. Actual results may differ from our estimates. The fair value of the convertible debt investment is recorded in long-term investments in our consolidated balance sheets.

~~Table of Contents~~foreign exchange forward contracts.

~~HURON CONSULTING GROUP INC.~~

~~NOTES TO CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Tabular amounts in thousands, except per share amounts)~~

~~(Unaudited)~~

~~The table below sets forth the changes in the balance of the convertible debt investment for the three months ended March 31, 2022.~~


	~~Convertible Debt Investment~~
~~Balance as of December 31, 2021~~	$	~~65,918~~

~~Change in fair value~~	~~(3,617)~~
~~Balance as of March 31, 2022~~	$	~~62,301~~

Deferred compensation assets: We have a non-qualified deferred compensation plan (the “Plan”) for the members of our board of directors and a select group of our employees. The deferred compensation liability is funded by the Plan assets, which consist of life insurance policies maintained within a trust. The cash surrender value of the life insurance policies approximates fair value and is based on third-party broker statements which provide the fair value of the life insurance policies' underlying investments, which are Level 2 inputs. The cash surrender value of the life insurance policies is invested primarily in mutual funds. The Plan assets are included in other non-current assets in our consolidated balance sheets. Realized and unrealized gains (losses) from the deferred compensation assets are recorded to other income (expense), net in our consolidated statements of operations.

Convertible debt investment: Since 2014, we have invested $40.9 million in the form of 1.69% convertible debt in Shorelight Holdings, LLC (“Shorelight”), the parent company of Shorelight, a U.S.-based company that partners with leading nonprofit universities to increase access to and retention of international students, boost institutional growth, and enhance an institution’s global footprint. The convertible notes will mature on January 17, 2027, unless converted earlier.

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

notes are not in-substance common stock that would warrant equity method accounting. After we reviewed all of the terms of the investment, we concluded the appropriate accounting treatment to be that of an available-for-sale debt security. We continue to monitor the key factors of our VIE analysis and the terms of the convertible notes to ensure our accounting treatment is appropriate. We have not identified any changes to Shorelight or our investment that would change our classification of the investment as an available-for-sale debt security.

The investment is carried at fair value with unrealized holding gains and losses excluded from earnings and reported in other comprehensive income. We estimate the fair value of our investment using a scenario-based approach in the form of a hybrid analysis that consists of a Monte Carlo simulation model and an expected return analysis. The conclusion of value for our investment is based on the probability-weighted assessment of both scenarios. The hybrid analysis utilizes certain assumptions including the assumed holding period through the maturity date of January 17, 2027; the applicable waterfall distribution at the end of the expected holding period based on the rights and privileges of the various instruments; cash flow projections discounted at the risk-adjusted rate of 23.5% and 24.0% as of March 31, 2023 and December 31, 2022, respectively; and the concluded equity volatility of 40.0% as of March 31, 2023 and December 31, 2022, all of which are Level 3 inputs. The use of alternative estimates and assumptions could increase or decrease the estimated fair value of the investment, which would result in different impacts to our consolidated balance sheet and comprehensive income. Actual results may differ from our estimates. The fair value of the convertible debt investment is recorded in long-term investments in our consolidated balance sheets.

The table below sets forth the changes in the balance of the convertible debt investment for the three months ended March 31, 2023.


	Convertible Debt Investment
Balance as of December 31, 2022	$	57,563

Change in fair value	5,279
Balance as of March 31, 2023	$	62,842

Contingent consideration for business acquisitions: We estimate the fair value of acquisition-related contingent consideration using either a probability-weighted assessment of the specific financial performance targets being measured or a Monte Carlo simulation model, as appropriate. These fair value measurements are based on significant inputs not observable in the market and thus represent Level 3 inputs. The significant unobservable inputs used in the fair value measurements of our contingent consideration are our measures of the estimated payouts based on internally generated financial projections on a probability-weighted basis and a discount rate which was ~~2.6%~~5.9% as of March 31, ~~2022. As~~2023 and 5.5% as of December 31, ~~2021, the discount rate used in the fair value measurements of our contingent consideration was in a range of 2.4% to 5.1% with a weighted average of 3.7%.~~2022. The fair value of the contingent consideration is reassessed quarterly based on assumptions used in our latest projections and input provided by practice leaders and management. Any change in the fair value estimate is recorded in our consolidated statement of operations for that period. The use of alternative estimates and assumptions could increase or decrease the estimated fair value of our contingent consideration liability, which would result in different impacts to our consolidated balance sheets and consolidated statements of operations. Actual results may differ from our estimates.

~~Table of Contents~~

~~HURON CONSULTING GROUP INC.~~

~~NOTES TO CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Tabular amounts in thousands, except per share amounts)~~

~~(Unaudited)~~

The table below sets forth the changes in the balance of the contingent consideration for business acquisitions for the three months ended March 31, ~~2022.~~2023.


	Contingent Consideration for Business Acquisitions
Balance as of December 31, ~~2021~~2022	$	~~3,743~~3,190
~~Acquisition~~	~~869~~
~~Payment~~	~~(4)~~
Change in fair value	12435
Balance as of March 31, ~~2022~~2023	$	~~4,620~~3,625

Financial assets and liabilities not recorded at fair value on a recurring basis are as follows:

Medically Home Preferred Stock Investment

In the fourth quarter of 2019, we invested $5.0 million in Medically Home Group, Inc. (“Medically Home”), a hospital-at-home company. The investment was made in the form of preferred stock. To determine the appropriate accounting treatment for our preferred stock investment, we performed a VIE analysis and concluded that Medically Home does not meet the definition of a VIE. We also reviewed the characteristics of our investment to confirm that the preferred stock is not in-substance common stock that would warrant equity method accounting. After we reviewed all of the terms of the investment, we concluded the appropriate accounting treatment for our investment in Medically Home to be that of an equity security with no readily determinable fair value. We elected to apply the measurement alternative at the time of the purchase and will continue to do so until the investment does not qualify to be so measured. Under the measurement alternative, the investment is carried at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for ~~the~~an identical or similar investment in Medically Home. On a quarterly basis, we review the information available to determine whether an

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

orderly and observable transaction for the same or similar equity instrument occurred, and remeasure to the fair value of the preferred stock using such identified transactions, with changes in the fair value recorded in our consolidated statement of operations.

~~As of December 31, 2021, the carrying amount of our preferred stock investment was $6.7 million.~~ During the first quarter of 2022, we recognized ana pre-tax unrealized gain of $27.0 ~~million to increase the carrying amount of our preferred stock investment to $33.6~~ million based on an observable price change of preferred stock issued by Medically Home with similar rights and preferences to our preferred stock ~~investment. This observable price change is~~investment, a Level 2 input. ~~The $27.0~~There were no observable price changes for the remainder of 2022 or in the first quarter of 2023. Since our initial investment, we have recognized cumulative pre-tax unrealized gains of $28.6 million, ~~unrealized gain is~~which were recorded to other income (expense), net in our consolidated statement of ~~operations. Since our initial investment,~~operations, and we ~~have recognized cumulative unrealized gains of $28.6 million. We~~ have not identified any impairments of our investment. As of March 31, 2023 and December 31, 2022, the carrying amount of our preferred stock investment was $33.6 million.

Senior Secured Credit Facility

The carrying value of our borrowings outstanding under our senior secured credit facility is stated at cost. Our carrying value approximates fair value, using Level 2 inputs, as the senior secured credit facility bears interest at variable rates based on current market rates as set forth in the Amended Credit Agreement. Refer to Note 76 “Financing Arrangements” for additional information on our senior secured credit facility.

~~Promissory Note due 2024~~

In the first quarter of 2022, we completed the sale of our aircraft to a third-party and used a portion of the sale proceeds to pay the remaining principal and unpaid interest on our promissory note due 2024. The carrying value of our promissory note due 2024 was stated at cost. The carrying value approximated fair value, using Level 2 inputs, as the promissory note bore interest at rates based on then-current market rates as set forth in the terms of the promissory note. Refer to Note 7 “Financing Arrangements” for additional information on our promissory note due 2024.

Cash and Cash Equivalents and Other Financial Instruments

Cash and cash equivalents are stated at cost, which approximates fair market value. The carrying values of all other financial instruments not described above reasonably approximate fair market value due to the nature of the financial instruments and the short-term maturity of these items.

~~Table of Contents~~

~~HURON CONSULTING GROUP INC.~~

~~NOTES TO CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Tabular amounts in thousands, except per share amounts)~~

~~(Unaudited)~~

~~11.~~10. Other Comprehensive Income (Loss)

The table below sets forth the components of other comprehensive income (loss), net of tax, for the three months ended March 31, ~~2022~~2023 and ~~2021.~~2022.
Three Months Ended
March 31, 2022 Three Months Ended
March 31, 2021
Before
Taxes Tax
(Expense)
Benefit Net of
Taxes Before
Taxes Tax
(Expense)
Benefit Net of
Taxes
Other comprehensive income (loss):
Foreign currency translation adjustments $ (43) $ — $ (43) $ 400 $ — $ 400
Unrealized gain (loss) on investment $ (3,617) $ 956 $ (2,661) $ (6,328) $ 1,680 $ (4,648)
Unrealized gain (loss) on cash flow hedges:
Change in fair value $ 5,668 $ (1,499) $ 4,169 $ 1,189 $ (337) $ 852
Reclassification adjustments into earnings 212 (56) 156 780 (203) 577
Net unrealized gain (loss) $ 5,880 $ (1,555) $ 4,325 $ 1,969 $ (540) $ 1,429
Other comprehensive income (loss) $ 2,220 $ (599) $ 1,621 $ (3,959) $ 1,140 $ (2,819)

~~The before tax amounts reclassified from accumulated other comprehensive income related to our cash flow hedges are recorded to interest expense, net of interest income.~~


	Three Months Ended March 31, 2023						Three Months Ended March 31, 2022
	Before Taxes		Tax (Expense) Benefit		Net of Taxes		Before Taxes		Tax (Expense) Benefit		Net of Taxes
Foreign currency translation adjustments	$	52	$	—	$	52	$	(43)	$	—	$	(43)
Unrealized gain (loss) on investment	$	5,279	$	(1,406)	$	3,873	$	(3,617)	$	956	$	(2,661)
Interest rate swaps:
Change in fair value	$	(1,807)	$	481	$	(1,326)	$	5,668	$	(1,499)	$	4,169
Reclassification adjustments into earnings	(1,532)		407		(1,125)		212		(56)		156
Net unrealized gain (loss) on interest rate swaps	$	(3,339)	$	888	$	(2,451)	$	5,880	$	(1,555)	$	4,325
Foreign exchange forward contracts:
Change in fair value	$	154	$	(41)	$	113	$	—	$	—	$	—
Reclassification adjustments into earnings	12		(3)		9		—		—		—
Net unrealized gain on foreign exchange forward contracts	$	166	$	(44)	$	122	$	—	$	—	$	—
Other comprehensive income (loss)	$	2,158	$	(562)	$	1,596	$	2,220	$	(599)	$	1,621

The before tax amounts reclassified from accumulated other comprehensive income related to our interest rate swaps and foreign exchange forward contracts are recorded to interest expense, net of interest income, and direct costs, respectively. Refer to Note 8 “Derivative Instruments and Hedging Activity” for additional information on our derivative instruments.

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

Accumulated other comprehensive income, net of tax, includes the following components:

Foreign Currency
Translation Available-for-Sale Investment Cash Flow Hedges Total
Balance, December 31, 2021 $ (1,143) $ 18,374 $ (391) $ 16,840
Current period change (43) (2,661) 4,325 1,621
Balance, March 31, 2022 $ (1,186) $ 15,713 $ 3,934 $ 18,461


					Cash Flow Hedges
	Foreign Currency Translation		Available-for-Sale Investment		Interest Rate Swaps		Foreign Exchange Forward Contracts		Total
Balance as of December 31, 2022	$	(3,033)	$	12,228	$	9,012	$	(88)	$	18,119
Current period change	52		3,873		(2,451)		122		1,596
Balance as of March 31, 2023	$	(2,981)	$	16,101	$	6,561	$	34	$	19,715

~~12.~~11. Income Taxes

For the three months ended March 31, 2023, our effective tax rate was 15.3% as we recognized income tax expense of $2.4 million on income of $15.8 million. The effective tax rate of 15.3% was more favorable than the statutory rate, inclusive of state income taxes, of 26.6%, primarily due to a discrete tax benefit for share-based compensation awards that vested during the quarter and a tax benefit related to non-taxable gains on our investments used to fund our deferred compensation liability. These favorable items were partially offset by certain nondeductible expense items.

For the three months ended March 31, 2022, our effective tax rate was 29.6% as we recognized income tax expense of $11.3 million on income of $38.1 million. The effective tax rate of 29.6% was less favorable than the statutory rate, inclusive of state income taxes, of 26.4%, primarily due to tax expense related to nondeductible losses on our investments used to fund our deferred compensation liability and certain nondeductible expense items.

For the three months ended March 31, 2021, our effective tax rate was 22.1% as we recognized income tax expense of $1.5 million on income of $6.9 million. The effective tax rate of 22.1% was more favorable than the statutory rate, inclusive of state income taxes, of 26.6%, primarily due to a discrete tax benefit for share-based compensation awards that vested during the first quarter of 2021. This favorable item was partially offset by certain nondeductible expense items

As of March 31, ~~2022,~~2023, we had ~~$0.7~~$0.6 million of unrecognized tax benefits which would affect the effective tax rate ~~of continuing operations~~ if recognized. It is reasonably possible that ~~approximately $0.1~~$0.6 million of the liability for unrecognized tax benefits could decrease in the next twelve months due to the expiration of statutes of limitations.

~~13.~~12. Commitments, Contingencies and Guarantees

Litigation

~~Oaktree~~

On November 9, 2018, Huron Consulting Services LLC, a wholly owned subsidiary of Huron, was engaged by Oaktree Medical Centre LLC, a management services organization (“Oaktree”), to perform interim management and financial advisory services. As part of the services, a Huron employee was appointed by Oaktree’s board of directors to serve as Chief Restructuring Officer of Oaktree (the “CRO”). The engagement letter through which Oaktree retained Huron’s services (the “Engagement Letter”) states that all disputes or claims arising

~~Table of Contents~~

~~HURON CONSULTING GROUP INC.~~

~~NOTES TO CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Tabular amounts in thousands, except per share amounts)~~

~~(Unaudited)~~

thereunder are subject to binding arbitration, disclaims special, consequential, incidental and exemplary damages and losses and caps liability to the fees paid for the portion of the engagement giving rise to any liability. On September 19, 2019, Oaktree and certain of its affiliates filed for Chapter 7 liquidation in the U.S. Bankruptcy Court for the Western District of North Carolina, with the cases subsequently transferred to the District of South Carolina. As a result of the bankruptcy filing, a Chapter 7 trustee was appointed to oversee the bankruptcy estates, at which time Huron’s services for Oaktree concluded.

In April 2021, Trustee’s counsel communicated in writing to Huron its intent to pursue various claims against Huron and the CRO, among others, on behalf of the bankruptcy estates related to the services carried out by Huron and the CRO during the engagement.

On September 17, 2021, the Trustee filed a complaint in the Bankruptcy Court for the District of South Carolina against Huron and the CRO, among others (the “Complaint”), alleging breach of fiduciary duty, aiding and abetting a breach of fiduciary duty, negligence, violations of the South Carolina Unfair Trade Practices Act, fraud, civil conspiracy, unjust enrichment, and recovery of avoided transfers under sections 547, 548 and 550 of the Bankruptcy Code. On December 7, 2021, the Trustee filed an amended version of the Complaint (the “Amended Complaint”), generally alleging the same claims asserted in the initial Complaint but (i) removing the claim for a violation of the South Carolina Unfair Trade Practices Act and (ii) adding a claim for breach of contract.

In the Amended Complaint, the Trustee asserted that Huron and the CRO, among others, did not develop and implement a Chapter 11 restructuring plan on a timely basis and that their failure to do so led to significant damages. The Trustee sought an unspecified amount of monetary damages in the Amended Complaint. We believe the Trustee’s allegations with respect to Huron and the CRO are without merit. On December 21, 2021, we filed a motion to dismiss all of the claims in the Amended Complaint. On April 19, 2022, the bankruptcy court entered an order staying all of the Trustee’s claims against Huron and the CRO after (i) finding that the state law claims were subject to arbitration and (ii) exercising its discretion to stay the non-state-law claims pending the arbitration proceeding. The Trustee has until May 3, 2022 to appeal the court’s order.~~Notwithstanding the foregoing, given the inherent risk and uncertainty associated with all litigation, we cannot estimate the potential liability with respect to such allegations at this time.~~

From time to time, we are involved in legal proceedings and litigation arising in the ordinary course of business. As of the date of this Quarterly Report on Form 10-Q, we are not a party to any litigation or legal proceeding or subject to any claim that, in the current opinion of management, could reasonably be expected to have a material adverse effect on our financial position or results of operations. However, due to the risks and uncertainties inherent in legal proceedings, actual results could differ from current expected results.

Guarantees

Guarantees in the form of letters of credit totaling $0.6 million and $0.7 million were outstanding ~~at both~~as of March 31, ~~2022~~2023 and December 31, ~~2021, primarily~~2022, respectively, to support certain office lease obligations.

In connection with certain business acquisitions, we may be required to pay post-closing consideration to the sellers if specific financial performance targets are met over a number of years as specified in the related purchase agreements. As of March 31, ~~2022~~2023 and December 31, ~~2021,~~2022, the total estimated fair value of our outstanding contingent consideration liability was ~~$4.6~~$3.6 million and ~~$3.7~~$3.2 million, respectively.

To the extent permitted by law, our bylaws and articles of incorporation require that we indemnify our officers and directors against judgments, fines and amounts paid in settlement, including attorneys’ fees, incurred in connection with civil or criminal action or proceedings, as it relates to their services to us if such person acted in good faith. Although there is no limit on the amount of indemnification, we may have recourse against our insurance carrier for certain payments made.

~~14.~~13. Segment Information

Segments are defined as components of a company that engage in business activities from which they may earn revenues and incur expenses, and for which separate financial information is available and is evaluated regularly by the chief operating decision maker, or decision-making group, in deciding how to allocate resources and in assessing performance. Our chief operating decision maker, who is our ~~chief executive officer, manages the business under 3 operating segments, which are our reportable segments: Healthcare, Education and Commercial.~~

Effective January 1, 2022, we modified our operating model to expand and more deeply integrate our industry expertise with our digital, strategic and financial advisory capabilities. The new operating model will strengthen Huron’s go-to-market strategy, drive efficiencies that support margin expansion, and position the company to accelerate growth.

1714

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

~~To align with~~chief executive officer, manages the ~~new~~business under three operating ~~model, effective with reporting for periods beginning January 1, 2022, we began reporting under the following three industries,~~segments, which are our reportable segments: Healthcare, Education and Commercial. The Commercial segment includes all industries outside of healthcare and education, including, but not limited to, financial services and energy and utilities. In the new reporting structure, each segment includes all revenue and costs associated with engagements delivered in the respective segments' industries. The new Healthcare and Education segments include some revenue and costs historically reported in the Business Advisory segment and the Healthcare segment includes some revenue and costs historically reported in the Education segment. We also provide revenue reporting across two principal capabilities: i) Consulting and Managed Services and ii) Digital. These changes create greater transparency for investors by improving visibility into the core drivers of our business. While our consolidated results have not been impacted, our historical segment information has been recast for consistent presentation.

•Healthcare

Our Healthcare segment serves acute care providers, including national and regional health ~~systems,~~systems; academic health ~~systems,~~systems; community health ~~systems,~~systems; and public, children’s and critical access hospitals, and non-acute care providers, including physician practices and medical ~~groups, payors,~~groups; payors; and long-term care or post-acute providers. Our Healthcare professionals have a depth of expertise in business operations, including financial and operational improvement, care transformation, and revenue cycle managed services; digital ~~solutions;~~solutions, spanning technology and analytic-related services and a portfolio of software products; organizational transformation; financial advisory and strategy and innovation. ~~Most healthcare~~Healthcare organizations are focused on establishing a sustainable long-term strategy and business model centered around growth, optimal cost structures, reimbursement models, financial strategies, and ~~financial strategies;~~consumer-focused digital transformation; changing the way care is delivered, particularly in light of personnel shortages, and improving access to care; and evolving their digital capabilities to more effectively manage their business. Our solutions help clients adapt to this rapidly changing healthcare environment to become a more agile, efficient and consumer-centric organization. We use our deep industry, functional and technical expertise to help clients solve a diverse set of business issues, including, but not limited to, identifying new opportunities for growth, optimizing financial and operational performance, improving care delivery and clinical outcomes, increasing physician, patient and employee satisfaction, and maximizing return on technology investments.

•Education

Our Education segment serves public and private colleges and universities, research institutes and other education-related organizations. Our Education professionals have a depth of expertise in strategy and innovation; business operations, including the research enterprise and student and alumni lifecycle; digital ~~solutions;~~solutions, spanning technology and analytic-related services and Huron Research Suite, the leading software suite designed to facilitate and improve research administration service delivery and compliance; and organizational transformation. Our Education segment clients are increasingly faced with strategic, financial and/or enrollment challenges, ~~as well as~~ increased ~~competition.~~competition, and a need to modernize their businesses using technology to advance their missions. We combine our deep industry, functional and technical expertise to help clients solve their most pressing challenges, including, but not limited to, transforming business operations with ~~technology;~~technology and analytics; strengthening research strategies and support services; evolving their organizational strategy; optimizing financial and operational performance; applying innovative enrollment strategies; and enhancing the student lifecycle.

•Commercial

Our Commercial segment is focused on serving industries and organizations facing significant disruption and regulatory change by helping them adapt to rapidly changing environments and accelerate business transformation. Our Commercial professionals work primarily with six primary buyers: the chief executive officer, the chief financial officer, the chief strategy officer, the chief human resources officer, the chief operating officer, and organizational advisors, including lenders and law firms. We have a deep focus on serving organizations in the financial services, energy and utilities, industrials and manufacturing industries and the public sector while opportunistically serving ~~the~~ commercial industries more broadly, including professional and business services, life sciences, consumer products, and nonprofit. Our Commercial professionals ~~have~~use their deep industry, functional and technical expertise ~~that they put forward when delivering~~to deliver our digital services and software products, strategy and innovation, and financial advisory (special situation advisory and corporate finance advisory) services. In today’s disruptive environment, organizations must reimagine their historical strategies and financial and operating models to sustain and advance their competitive advantage. Our experts help organizations across industries with a variety of business challenges, including, but not limited to, embedding technology and analytics throughout their internal and customer-facing ~~operations,~~operations; developing analytics and insights ~~into~~to identify the needs of tomorrow’s customers, ~~in order to evolve~~evolving their ~~enterprise~~strategies, and ~~business unit strategies,~~ bringing new products to ~~market,~~market; managing through stressed and distressed situations to create a viable path forward for ~~stakeholders~~stakeholders; and ~~executing mergers~~providing financial, risk and ~~acquisitions, finance offerings and risk mitigation strategies.~~regulatory advisory offerings.

Segment operating income consists of the revenues generated by a segment, less operating expenses that are incurred directly by the segment. Unallocated costs include corporate costs related to administrative functions that are performed in a centralized manner that are not attributable to a particular segment. These administrative function costs include corporate office support costs, office facility costs, costs

~~Table of Contents~~

~~HURON CONSULTING GROUP INC.~~

~~NOTES TO CONSOLIDATED FINANCIAL STATEMENTS~~

~~(Tabular amounts in thousands, except per share amounts)~~

~~(Unaudited)~~

related to accounting and finance, human resources, legal, marketing, information technology, and company-wide business development functions, as well as costs related to overall corporate management. Our chief operating decision maker does not evaluate segments using asset information.

The table below sets forth information about our operating segments for the three months ended March 31, 2022 and 2021, along with the items necessary to reconcile the segment information to the totals reported in the accompanying consolidated financial statements.

Three Months Ended
March 31,
2022 2021
Healthcare:
Revenues $ 121,876 $ 95,975
Operating income $ 28,032 $ 23,827
Segment operating income as a percentage of segment revenues 23.0 % 24.8 %
Education:
Revenues $ 80,662 $ 51,342
Operating income $ 14,306 $ 8,537
Segment operating income as a percentage of segment revenues 17.7 % 16.6 %
Commercial:
Revenues $ 57,511 $ 55,896
Operating income $ 12,214 $ 9,850
Segment operating income as a percentage of segment revenues 21.2 % 17.6 %
Total Huron:
Revenues $ 260,049 $ 203,213
Reimbursable expenses 4,726 1,934
Total revenues and reimbursable expenses $ 264,775 $ 205,147
Segment operating income $ 54,552 $ 42,214
Items not allocated at the segment level:
Other operating expenses 33,548 28,879
Depreciation and amortization 5,046 5,095
Operating income 15,958 8,240
Other income (expense), net 22,169 (1,299)
Income before taxes $ 38,127 $ 6,941

The following table illustrates the disaggregation of revenues by capability, including a reconciliation of the disaggregated revenues to revenues from our 3 operating segments for the three months ended March 31, 2022 and 2021.
Three Months Ended March 31, 2022
Healthcare Education Commercial Total
Capability
Consulting and Managed Services $ 83,759 $ 44,181 $ 22,644 $ 150,584
Digital 38,117 36,481 34,867 109,465
Total $ 121,876 $ 80,662 $ 57,511 $ 260,049
Three Months Ended March 31, 2021
Healthcare Education Commercial Total
Capability
Consulting and Managed Services $ 66,929 $ 28,033 $ 27,589 $ 122,551
Digital 29,046 23,309 28,307 80,662
Total $ 95,975 $ 51,342 $ 55,896 $ 203,213

1915

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

The table below sets forth information about our operating segments for the three months ended March 31, 2023 and 2022, along with the items necessary to reconcile the segment information to the totals reported in the accompanying consolidated financial statements.


	Three Months Ended March 31,
		2023			2022
Healthcare:
Revenues		$	149,049		$	121,876
Operating income		$	32,255		$	28,032
Segment operating income as a percentage of segment revenues		21.6		%	23.0		%
Education:
Revenues		$	104,147		$	80,662
Operating income		$	23,165		$	14,306
Segment operating income as a percentage of segment revenues		22.2		%	17.7		%
Commercial:
Revenues		$	64,699		$	57,511
Operating income		$	14,067		$	12,214
Segment operating income as a percentage of segment revenues		21.7		%	21.2		%
Total Huron:
Revenues		$	317,895		$	260,049
Reimbursable expenses		8,490			4,726
Total revenues and reimbursable expenses		$	326,385		$	264,775

Segment operating income		$	69,487		$	54,552
Items not allocated at the segment level:
Other operating expenses		46,340			33,548
Depreciation and amortization		4,716			5,046

Operating income		18,431			15,958
Total other income (expense), net		(2,584)			22,169
Income before taxes		$	15,847		$	38,127

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

The following table illustrates the disaggregation of revenues by our two principal capabilities: i) Consulting and Managed Services and ii) Digital, and includes a reconciliation of the disaggregated revenues to revenues from our three operating segments for the three months ended March 31, 2023 and 2022.


	Three Months Ended March 31,
Revenues by Capability		2023		2022
Healthcare:
Consulting and Managed Services		$	101,736	$	83,759
Digital		47,313		38,117
Total revenues		$	149,049	$	121,876
Education:
Consulting and Managed Services		$	53,227	$	44,181
Digital		50,920		36,481
Total revenues		$	104,147	$	80,662
Commercial:
Consulting and Managed Services		$	22,231	$	22,644
Digital		42,468		34,867
Total revenues		$	64,699	$	57,511
Total Huron:
Consulting and Managed Services		$	177,194	$	150,584
Digital		140,701		109,465
Total revenues		$	317,895	$	260,049

For the three months ended March 31, ~~2022~~2023 and ~~2021,~~2022, substantially all of our revenues were recognized over time. At March 31, ~~2022~~2023 and December 31, ~~2021,~~2022, no single client accounted for greater than 10% of our combined balance of receivables from clients, net and unbilled services, net. During the three months ended March 31, ~~2022~~2023 and ~~2021,~~2022, no single client generated greater than 10% of our consolidated revenues.

2017

Table of Contents


ITEM 2.			MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

In this Quarterly Report on Form 10-Q, unless the context otherwise requires, the terms “Huron,” “Company,” “we,” “us” and “our” refer to Huron Consulting Group Inc. and its subsidiaries.

Statements in this Quarterly Report on Form 10-Q that are not historical in nature, including those concerning the Company’s current expectations about its future results, are “forward-looking” statements as defined in Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and the Private Securities Litigation Reform Act of 1995. Forward-looking statements are identified by words such as “may,” “should,” “expects,” “provides,” “anticipates,” “assumes,” “can,” “will,” “meets,” “could,” “likely,” “intends,” “might,” “predicts,” “seeks,” “would,” “believes,” “estimates,” “plans,” “continues,” “goals,” “guidance,” or “outlook,” or similar expressions. These forward-looking statements reflect our current expectations about our future requirements and needs, results, levels of activity, performance, or achievements. Some of the factors that could cause actual results to differ materially from the forward-looking statements contained herein include, without limitation: the impact of the COVID-19 pandemic on the economy; our clients and client demand for our services, and our ability to sell and provide services, including the measures taken by governmental authorities and businesses in response to the pandemic, which may cause or contribute to other risks and uncertainties that we face; failure to achieve expected utilization rates, billing rates, and the necessary number of revenue-generating professionals; inability to expand or adjust our service offerings in response to market demands; our dependence on renewal of client-based services; dependence on new business and retention of current clients and qualified personnel; failure to maintain third-party provider relationships and strategic alliances; inability to license technology to and from third parties; the impairment of goodwill; various factors related to income and other taxes; difficulties in successfully integrating the businesses we acquire and achieving expected benefits from such acquisitions; risks relating to privacy, information security, and related laws and standards; and a general downturn in market conditions. These forward-looking statements involve known and unknown risks, uncertainties, and other factors, including, among others, those described under Item 1A. “Risk Factors,” in our Annual Report on Form 10-K for the year ended December 31, ~~2021~~2022 that may cause actual results, levels of activity, performance or achievements to be materially different from any anticipated results, levels of activity, performance, or achievements expressed or implied by these forward-looking statements. We disclaim any obligation to update or revise any forward-looking statements as a result of new information or future events, or for any other reason.

OVERVIEW

Our Business

~~Effective January 1, 2022, we modified~~We provide our ~~operating model to expand~~services and ~~more deeply integrate~~products and manage our ~~industry expertise with our digital, strategic and financial advisory capabilities. The new~~business under three operating ~~model will strengthen Huron’s go-to-market strategy, drive efficiencies that support margin expansion, and position the company to accelerate growth.~~

~~To align with the new operating model, effective with reporting for periods beginning January 1, 2022, we began reporting under the following three industries, which are our reportable~~ segments: Healthcare, Education and Commercial. The Commercial segment includes all industries outside of healthcare and education, including, but not limited to, financial services and energy and utilities. In the new reporting structure, each segment includes all revenue and costs associated with engagements delivered in the respective segments' industries. The new Healthcare and Education segments include some revenue and costs historically reported in the Business Advisory segment and the Healthcare segment includes some revenue and costs historically reported in the Education segment. We also provide revenue reporting across two principal capabilities: i) Consulting and Managed Services and ii) Digital. ~~These changes create greater transparency for investors by improving visibility into the core drivers~~

Capabilities

Within each of our ~~business. While~~reportable segments, we provide services under two principal capabilities: i) Consulting and Managed Services and ii) Digital.

•Consulting and Managed Services

Our Consulting and Managed Services capabilities represent our ~~consolidated results~~management consulting services, managed services (excluding technology-related managed services) and outsourcing services delivered across industries. Our Consulting and Managed Services experts help our clients address a variety of strategic, operational, financial, people and organizational-related challenges. These services are often combined with technology, analytic and data-driven solutions powered by our Digital capability to support long-term relationships with our clients and drive lasting impact. Examples include the areas of revenue cycle management and research administration at our healthcare and education clients, where our consulting and managed services projects are often coupled with our digital services and product offerings.

•Digital

Our Digital capabilities represent our technology and analytics services, including technology-related managed services and software products delivered across industries. Our Digital experts help clients address a variety of business challenges, including, but not limited to, designing and implementing technologies to accelerate transformation, facilitate data-driven decision making and improve customer and employee experiences.

We have ~~not been impacted,~~expanded our ~~historical segment information has been recast for consistent presentation. See below for additional information on~~ecosystem to work with more than 25 technology partners. We are a Leading Modern Oracle Network Partner; a Summit-level consulting partner with Salesforce.com and a Premium Partner with Salesforce.org; a Workday Services, Preferred Channel, Extend, and Application Management Services Partner; an Amazon Web Services consulting partner; an Informatica Platinum Partner; an SAP Concur implementation partner; and a Boomi Elite Partner.

Table of Contents

We have also grown our ~~operating industries~~proprietary software product portfolio to address our clients' challenges with solutions that expand our base of recurring revenue and ~~principal capabilities.~~further differentiate our consulting, digital and managed services offerings. Our product portfolio bundles our deep industry expertise and unique intellectual property together to serve our clients outside of our traditional consulting offerings. Our product portfolio includes, among others: Huron Research Suite, the leading software suite designed to facilitate and improve research administration service delivery and compliance; Huron Intelligence™ Rounding, the #1 ranked Digital Rounding solution in the 2023 Best in KLAS® report; and Huron Intelligence™ Analytic Suite in Healthcare, a predictive analytics suite to improve care delivery while lowering costs.

Operating Industries

We provide our services and products and manage our business under three operating industries, which are ~~also~~ our operating segments: Healthcare, Education and Commercial.

•Healthcare

~~Table of Contents~~

evolving their digital capabilities to more effectively manage their business. Our solutions help clients adapt to this rapidly changing healthcare environment to become a more agile, efficient and consumer-centric organization. We use our deep industry, functional and technical expertise to help clients solve a diverse set of business issues, including, but not limited to, identifying new opportunities for growth, optimizing financial and operational performance, improving care delivery and clinical outcomes, increasing physician, patient and employee satisfaction, and maximizing return on technology investments.

•Education

•Commercial

~~Capabilities~~

~~Within each of our reportable segments, we provide services under two principal capabilities: i) Consulting and Managed Services and ii) Digital.~~

•~~Consulting and Managed Services~~

Our Consulting and Managed Services capabilities represent all of our management consulting services, managed services (excluding technology-related managed services) and outsourcing services delivered across industries. Our Consulting and Managed Services experts help our clients address a variety of strategic, operational, financial, people and organizational-related challenges.

•~~Digital~~

Our Digital capabilities represent all of our technology and analytics services, including technology-related managed services, and software products revenue delivered across industries. Our Digital experts help our clients address a variety of business challenges, including, but not limited to, designing and implementing technologies to accelerate transformation, facilitate data-driven decision making and improve customer and employee experiences.

We have expanded our ecosystem to work with more than 25 technology partners, and we are an Oracle partner, a Gold-level consulting partner with Salesforce.com and a Premium Partner with Salesforce.org, a Workday Services and Software Partner, an Amazon Web Services consulting partner, a Silver-level system integrator with Informatica and an SAP Concur implementation partner.

~~Business Strategy, Opportunities and Challenges~~

Our primary strategy is to be the premier transformation partner to our clients, meeting their needs by providing a balanced portfolio of service and product offerings so that we can adapt quickly and effectively to emerging opportunities in the marketplace. To achieve our strategic and financial objectives, we remain focused on accelerating growth in healthcare and education, growing our presence in the commercial industries, advancing our integrated digital platform, building a more sustainable base of revenue to drive more consistent growth, strategically deploying capital to accelerate our strategy and return capital to shareholders, and investing in and growing our talented team, including attracting and retaining ourregulatory advisory offerings.

2219

Table of Contents

Business Strategy, Opportunities and Challenges

Our strategy is to be the premier transformation partner to our clients by helping them address a variety of strategic, operational, financial, people, and organizational challenges through an array of industry-differentiated consulting, digital and managed services offerings that meet their unique needs. To achieve our strategic and financial objectives that will drive increased shareholder value, we remain focused on:

•Extending our leading market positions and accelerating growth in healthcare and education,

•Growing our presence in commercial industries,

•Advancing our integrated, global digital platform,

•Building a more sustainable base of revenue and executing on our margin levers to drive more consistent growth and improved profitability,

•Strategically deploying capital to accelerate our strategy and return capital to shareholders, and

•Investing in and growing our talented team, including attracting and retaining our managing directors ~~our~~- the senior most practitioners that lead our revenue generation efforts.

We regularly evaluate the performance of our businesses to ensure our investments meet these objectives.

COMPONENTS OF OPERATING RESULTS

Revenues

Our revenues are primarily generated by our employees who provide consulting and other professional services to our clients and are billable to our clients based on the number of hours worked, services provided, or achieved outcomes. We refer to these employees as our revenue-generating professionals. Revenues are primarily driven by the number of revenue-generating professionals we employ as well as the total value, scope, and terms of the consulting contracts under which they provide services. We also engage independent contractors to supplement our revenue-generating professionals on client engagements as needed.

We generate our revenues from providing professional services and software products under the following four types of billing arrangements: fixed-fee (including software license revenue); time-and-expense; performance-based; and software support, maintenance and subscriptions.

•Fixed-fee (including software license revenue): In fixed-fee billing arrangements, we agree to a pre-established fee in exchange for a predetermined set of professional services. We set the fees based on our estimates of the costs and timing for completing the engagements. Fixed-fee arrangements also include software licenses for our revenue cycle management software and research administration and compliance software.

•Time-and-expense: Under time-and-expense billing arrangements, we require the client to pay based on the number of hours worked by our revenue-generating professionals at agreed upon rates. Time-and-expense arrangements also include speaking engagements, conferences and publications purchased by our clients.

•Performance-based: In performance-based fee billing arrangements, fees are tied to the attainment of contractually defined objectives. We enter into performance-based engagements in essentially two forms. First, we generally earn fees that are directly related to the savings formally acknowledged by the client as a result of adopting our recommendations for improving operational and cost effectiveness in the areas we review. Second, we earn a success fee when and if certain predefined outcomes occur. Often, performance-based fees supplement our time-and-expense or fixed-fee engagements. The level of performance-based fees earned may vary based on our clients’ risk sharing preferences and the mix of services we provide.

•Software support, maintenance and subscriptions: Clients that have purchased one of our software licenses can pay an annual fee for software support and maintenance. We also generate subscription revenue from our cloud-based analytic tools and solutions. Software support, maintenance and subscription revenues are recognized ratably over the support or subscription period. These fees are generally billed in advance and included in deferred revenues until recognized.

Time-and-expense engagements do not provide us with a high degree of predictability as to performance in future periods. Unexpected changes in the demand for our services can result in significant variations in utilization and revenues and present a challenge to optimal hiring and staffing. Moreover, our clients typically retain us on an engagement-by-engagement basis, rather than under long-term recurring contracts. The volume of work performed for any particular client can vary widely from period to period.

Our quarterly results are impacted principally by the total value, scope, and terms of our client contracts, the number of our revenue-generating professionals who are available to work, our revenue-generating professionals' utilization rate, and the bill rates we charge our clients. Our utilization rate can be negatively affected by increased hiring because there is generally a transition period for new professionals that results in a temporary

Table of Contents

drop in our utilization rate. Our utilization rate can also be affected by seasonal variations in the demand for our services from our clients. For example, during the third and fourth quarters of the year, vacations taken by our clients can result in the deferral of activity on existing and new engagements, which would negatively affect our utilization rate. The number of business work days is also affected by the number of vacation days taken by our consultants and holidays in each quarter. We typically have fewer business work days available in the fourth quarter of the year, which can impact revenues during that period.

Reimbursable Expenses

Reimbursable expenses that are billed to clients, primarily relating to travel and out-of-pocket expenses incurred in connection with client engagements, are included in total revenues and reimbursable expenses. Reimbursable expenses are recognized as expenses in the period in which the expense is incurred. Subcontractors that are billed to clients at cost are also included in reimbursable expenses. When billings do not specifically identify reimbursable expenses, we allocate the portion of the billings equivalent to these expenses to reimbursable expenses.

We manage our business on the basis of revenues before reimbursable expenses, which we believe is the most accurate reflection of our services because it eliminates the effect of reimbursable expenses that we bill to our clients at cost.

~~Table of Contents~~

Operating Expenses

Our most significant expenses are costs classified as direct costs. Direct costs primarily consist of ~~payroll~~compensation costs for our revenue-generating professionals, which includes salaries, performance bonuses, share-based compensation, signing and retention bonuses, payroll taxes and ~~benefits for our revenue-generating professionals.~~benefits. Direct costs also include fees paid to independent contractors that we retain to supplement our revenue-generating professionals, typically on an as-needed basis for specific client engagements, and technology costs, product and event costs, and commissions. Direct costs exclude amortization of intangible assets and software development costs and reimbursable expenses, both of which are separately presented in our consolidated statements of operations.

Selling, general and administrative expenses consist primarily of ~~salaries, performance bonuses, payroll taxes, benefits, and share-based~~ compensation costs for our support personnel. Also included in selling, general and administrative expenses is third-party professional fees, software licenses and data hosting expenses, rent and other office related expenses, sales and marketing related expenses, recruiting and training expenses, and practice administration and meetings expenses.

Other operating expenses include restructuring charges, depreciation expense, ~~and~~ amortization expense related to internally developed software costs and amortization of intangible assets acquired in business combinations. In the first quarter of 2022, we began presenting depreciation and amortization expense inclusive of amortization of intangible assets and software development costs previously presented within total direct costs and reimbursable expenses. We have recast our historical presentation of our consolidated statement of operations for consistent presentation.

~~Segment Results~~

Segment operating income consists of the revenues generated by a segment, less operating expenses that are incurred directly by the segment. ~~Unallocated costs~~Other operating expenses not allocated at the segment level include corporate costs related to administrative functions that are performed in a centralized manner that are not attributable to a particular segment. These administrative function costs include corporate office support costs, office facility costs, costs related to accounting and finance, human resources, legal, marketing, information technology, and company-wide business development functions, ~~as well as~~and costs related to overall corporate management.

Non-GAAP Measures

We also assess our results of operations using the following non-GAAP financial measures: earnings before interest, taxes, depreciation and amortization (“EBITDA”), adjusted EBITDA, adjusted EBITDA as a percentage of revenues, adjusted net income, and adjusted diluted earnings per share ~~("EPS"~~(“EPS”). These non-GAAP financial measures differ from GAAP because they exclude a number of items required by GAAP, each discussed below. These non-GAAP financial measures should be considered in addition to, and not as a substitute for or superior to, any measure of performance, cash flows, or liquidity prepared in accordance with GAAP. Our non-GAAP financial measures may be defined differently from time to time and may be defined differently than similar terms used by other companies, and accordingly, care should be exercised in understanding how we define our non-GAAP financial measures.

Our management uses the non-GAAP financial measures to gain an understanding of our comparative operating performance, for example when comparing such results with previous periods or forecasts. These non-GAAP financial measures are used by management in their financial and operating decision making because management believes they reflect our ongoing business in a manner that allows for meaningful period-to-period comparisons. Management also uses these non-GAAP financial measures when publicly providing our business outlook, for internal management purposes, and as a basis for evaluating potential acquisitions and dispositions. We believe that these non-GAAP financial measures provide useful information to investors and others in understanding and evaluating Huron’s current operating performance and future prospects in the same manner as management does and in comparing in a consistent manner Huron’s current financial results with Huron’s past financial results.

These non-GAAP financial measures include adjustments for the following items:

Amortization of intangible assets: We exclude the effect of amortization of intangible assets from the calculation of adjusted net income, as it is inconsistent in its amount and frequency and is significantly affected by the timing and size of our acquisitions.

Restructuring charges: We have incurred charges due to ~~the~~ restructuring of various parts of our business. These restructuring charges have primarily consisted of costs associated with office space consolidations, including lease impairment charges and accelerated depreciation on lease-related property and equipment, and employee severance charges. We exclude the effect of the restructuring charges from our non-GAAP measures to permit comparability with periods that are not impacted by these items.

Table of Contents

Other losses (gains): We exclude the ~~effect~~effects of other losses (gains), which primarily relate to changes in the estimated fair value of our liabilities for contingent consideration related to business acquisitions and litigation settlement losses and gains, to permit comparability with periods that are not impacted by these items.

Transaction-related expenses: To permit comparability with prior periods, we exclude the impact of third-party legal and accounting fees incurred related to business acquisitions.

~~Table of Contents~~

Unrealized gain on preferred stock investment: We exclude the effect of unrealized gains related to changes in the fair value of our preferred stock investment in Medically Home Group, Inc. (“Medically Home”), which are recognized when an observable price change occurs. These unrealized gains are included as a component of other income (expense), net. We believe that these unrealized gains are not indicative of the ongoing performance of our business and their exclusion permits comparability with prior periods.

Foreign currency transaction losses (gains), net: We exclude the effect of foreign currency transaction losses and gains from the calculation of adjusted EBITDA because the amount of each loss or gain is significantly affected by changes in foreign exchange rates.

Tax effect of adjustments: The non-GAAP income tax adjustment reflects the incremental tax impact applicable to the non-GAAP adjustments.

Income tax expense, Interest expense, net of interest income, Depreciation and amortization: We exclude the effects of income tax expense, interest expense, net of interest income, and depreciation and amortization in the calculation of EBITDA, as these are customary exclusions as defined by the calculation of EBITDA to arrive at meaningful earnings from core operations excluding the effect of such items. We include, within the depreciation and amortization adjustment, the amortization of capitalized implementation costs of our ~~ERP~~enterprise resource planning ("ERP") and other related software, which is included within selling, general and administrative expenses onin our consolidated ~~statement~~statements of operations.

Revenue-Generating Professionals

Our revenue-generating professionals consist of our full-time consultants who generate revenues based on the number of hours worked; full-time equivalents, which consists of coaches and their support staff within the Culture and Organizational excellence solution, consultants who work variable schedules as needed by clients, and full-time employees who provide software support and maintenance services to clients; and our Healthcare Managed Services employees who provide revenue cycle billing, collections insurance verification and change integrity services to clients.

Utilization Rate

The utilization rate of our revenue-generating professionals is calculated by dividing the number of hours our billable consultants worked on client assignments during a period by the total available working hours for these billable consultants during the same period. Available hours are determined by the standard hours worked by each billable consultant, adjusted for part-time hours, and U.S. standard work weeks. Available working hours exclude local country holidays and vacation days. Utilization rates are presented for our revenue-generating professionals who primarily bill on an hourly basis. We do not present utilization rates for our Managed Services professionals as most of the revenues generated by these employees are not billed on an hourly basis.

RESULTS OF OPERATIONS

Executive Highlights

Highlights from the first quarter of ~~2022~~2023 include:

•~~Revenues~~Total revenues increased ~~28.0%~~22.2% to $317.9 million for the first quarter of 2023 from $260.0 million for the first quarter of 2022 ~~from $203.2 million for the first quarter of 2021~~

•Revenues within our Digital capability increased ~~35.7%~~28.5% in the first quarter of ~~2022,~~2023, compared to the first quarter of ~~2021~~2022

•~~Operating margin increased to 6.1%~~Diluted EPS was $0.68 for the first quarter of ~~2022,~~2023; compared ~~to 4.1% for the first quarter of 2021~~

•~~Diluted EPS increased~~ to $1.27 for the first quarter of 2022 ~~compared to $0.24 for the first quarter~~which included a $19.8 million unrealized gain, net of ~~2021~~tax, on our preferred stock investment

•Adjusted diluted EPS increased 77.6% to $0.87 for the first quarter of 2023, compared to $0.49 for the first quarter of 2022 ~~compared~~

•Returned $44.3 million to ~~$0.35~~shareholders by repurchasing 632,894 shares of our common stock in the first quarter of 2023

Total revenues increased $57.8 million, or 22.2%, to $317.9 million for the first quarter of ~~2021~~

•~~Returned $24.1 million to shareholders through share repurchases in the first quarter of 2022~~

~~Revenues increased $56.8 million, or 28.0%, to~~2023 from $260.0 million for the first quarter of ~~2022 from $203.2 million for the first quarter of 2021.~~2022. The increase in revenues reflects continued strength in demand for our Digital capability services across all segments; as well as strengthened demand for ~~services in all of~~ our ~~segments, as well as the favorable comparison against results for the first quarter of 2021 in~~Consulting and Managed Services offerings within our Healthcare and Education segments, which ~~were more significantly impacted by the COVID-19 pandemic as some clients reprioritized and delayed certain projects as a result of the uncertainties surrounding the pandemic. Beginning~~reflects our focus on accelerating growth in the ~~second quarter~~healthcare and education industries.

Table of 2021, we saw strengthened demand for our services and an increase in our pipeline that continued through 2021 and into 2022. Revenues for the first quarter of 2022 increased 4.7% compared to the fourth quarter of 2021.Contents

In our Consulting and Managed Services capability, revenues for the first quarter of ~~2022~~2023 increased ~~22.9%~~17.7%, compared to the first quarter of ~~2021,~~2022, and reflected strengthened demand in our Healthcare and Education segments. The utilization rate within our Consulting capability increased to 76.3% in the first quarter of 2023, compared to 71.4% in the first quarter of ~~2022, compared to 66.4% in the first quarter of 2021.~~

~~Table of Contents~~

2022.

Revenues within our Digital capability increased ~~35.7%~~28.5% in the first quarter of ~~2022~~2023 compared to the first quarter of ~~2021,~~2022, and reflected ~~strengthened~~strength in demand in all of our segments. The utilization rate within our Digital capability ~~increased~~decreased to 71.0% in the first quarter of 2023, compared to 72.4% in the first quarter of ~~2022, compared to 71.3% in the first quarter of 2021.~~2022.

The total number of revenue-generating professionals increased to 5,013 as of March 31, 2023, compared to 4,023 as of March 31, 2022, ~~compared to 3,116 as of March 31, 2021,~~ as a result of hiring to support the overall increase in demand for our services ~~particularly~~ within all of our ~~Healthcare and Education segments, as well as headcount increases in connection with business acquisitions.~~segments. We proactively plan and manage the size and composition of our workforce and take actions as needed to address changes in the anticipated demand for our services as ~~payroll~~employee compensation costs are the most significant portion of our operating expenses.

Operating margin, which is defined as operating income expressed as a percentage of revenues, increased to 6.1% for the three months ended March 31, 2022 compared to 4.1% for the three months ended March 31, 2021, driven by strong revenue growth that outpaced increases in operating expenses.

Net income ~~increased $21.4~~decreased $13.4 million to ~~$26.9~~$13.4 million for the three months ended March 31, ~~2022~~2023 from ~~$5.4~~$26.9 million for the same period last ~~year. The increase in net income was primarily attributable to a~~year, driven by the $19.8 million unrealized gain, net of tax, recognized in the first quarter of 2022 related to the increase in ~~the~~ fair value of our preferred stock ~~investment in Medically Home.~~investment. As a result of the ~~increase~~decrease in net income, diluted earnings per share for the first quarter of ~~2022~~2023 was ~~$1.27~~$0.68 compared to ~~$0.24~~$1.27 for the first quarter of ~~2021.~~2022. Adjusted diluted earnings per share ~~was~~increased 77.6% to $0.87 for the first quarter of 2023, compared to $0.49 for the first quarter of ~~2022, compared to $0.35 for the first quarter of 2021.~~2022.

During the first quarter of ~~2022,~~2023, we ~~repurchased 523,399~~deployed $44.3 million of capital to repurchase 632,894 shares ~~for $23.9 million and settled the repurchase~~ of ~~3,820 shares for $0.2 million that were accrued~~our common stock, representing 3.2% of our common stock outstanding as of December 31, ~~2021 for a total repurchase of 527,219 shares for $24.1 million.~~2022.

Summary of Results

Effective January 1, 2022, we modified our operating model to expand and more deeply integrate our industry expertise with our digital, strategic and financial advisory capabilities. The new operating model will strengthen Huron’s go-to-market strategy, drive efficiencies that support margin expansion, and position the company to accelerate growth.

To align with the new operating model, effective with reporting for periods beginning January 1, 2022, we began reporting under the following three industries, which are our reportable segments: Healthcare, Education and Commercial. The Commercial segment includes all industries outside of healthcare and education, including, but not limited to, financial services and energy and utilities. In the new reporting structure, each segment includes all revenue and costs associated with engagements delivered in the respective segments' industries. The new Healthcare and Education segments include some revenue and costs historically reported in the Business Advisory segment and the Healthcare segment includes some revenue and costs historically reported in the Education segment. We also provide revenue reporting across two principal capabilities: i) Consulting and Managed Services and ii) Digital. These changes create greater transparency for investors by improving visibility into the core drivers of our business. While our consolidated results have not been impacted, our historical segment information has been recast for consistent presentation.

The following table sets forth, for the periods indicated, selected segment and consolidated operating results and other operating data, including non-GAAP measures.


Segment and Consolidated Operating Results (in thousands, except per share amounts):	Segment and Consolidated Operating Results (in thousands, except per share amounts):	Three Months Ended March 31,				Segment and Consolidated Operating Results (in thousands, except per share amounts):					Three Months Ended March 31,
			2022				2021			Segment and Consolidated Operating Results (in thousands, except per share amounts):		2023			2022
Healthcare:	Healthcare:
Revenues	Revenues		$	121,876			$	95,975		Revenues		$	149,049		$	121,876
Operating income	Operating income		$	28,032			$	23,827		Operating income		$	32,255		$	28,032
Segment operating income as a percentage of segment revenues	Segment operating income as a percentage of segment revenues		23.0		%		24.8		%	Segment operating income as a percentage of segment revenues		21.6		%	23.0		%
Education:	Education:									Education:
Revenues	Revenues		$	80,662			$	51,342		Revenues		$	104,147		$	80,662
Operating income	Operating income		$	14,306			$	8,537		Operating income		$	23,165		$	14,306
Segment operating income as a percentage of segment revenues	Segment operating income as a percentage of segment revenues		17.7		%		16.6		%	Segment operating income as a percentage of segment revenues		22.2		%	17.7		%
Commercial:	Commercial:									Commercial:
Revenues	Revenues		$	57,511			$	55,896		Revenues		$	64,699		$	57,511
Operating income	Operating income		$	12,214			$	9,850		Operating income		$	14,067		$	12,214
Segment operating income as a percentage of segment revenues	Segment operating income as a percentage of segment revenues		21.2		%		17.6		%	Segment operating income as a percentage of segment revenues		21.7		%	21.2		%
Total Huron:	Total Huron:									Total Huron:
Revenues	Revenues		$	260,049			$	203,213		Revenues		$	317,895		$	260,049
Reimbursable expenses	Reimbursable expenses		4,726				1,934			Reimbursable expenses		8,490			4,726
Total revenues and reimbursable expenses	Total revenues and reimbursable expenses		$	264,775			$	205,147		Total revenues and reimbursable expenses		$	326,385		$	264,775

Segment operating income	Segment operating income		$	54,552			$	42,214		Segment operating income		$	69,487		$	54,552
Items not allocated at the segment level:										Items not allocated at the segment level:
Other operating expenses										Other operating expenses		46,340			33,548
Depreciation and amortization										Depreciation and amortization		4,716			5,046
Operating income										Operating income		18,431			15,958
Total other income (expense), net										Total other income (expense), net		(2,584)			22,169
Income before taxes										Income before taxes		15,847			38,127
Income tax expense										Income tax expense		2,428			11,275
Net income										Net income		$	13,419		$	26,852
Earnings per share:										Earnings per share:
Basic										Basic		$	0.70		$	1.29
Diluted										Diluted		$	0.68		$	1.27

2623

Table of Contents


Segment and Consolidated Operating Results (in thousands, except per share amounts):	Segment and Consolidated Operating Results (in thousands, except per share amounts):	Three Months Ended March 31,				Segment and Consolidated Operating Results (in thousands, except per share amounts):					Three Months Ended March 31,
			2022				2021			Segment and Consolidated Operating Results (in thousands, except per share amounts):		2023			2022
Items not allocated at the segment level:
Other operating expenses			33,548				28,879
Depreciation and amortization			5,046				5,095
Operating income			15,958				8,240
Other income (expense), net			22,169				(1,299)
Income before taxes			38,127				6,941
Income tax expense			11,275				1,536
Net income			$	26,852			$	5,405
Earnings per share:
Basic			$	1.29			$	0.25
Diluted			$	1.27			$	0.24

Other Operating Data:	Other Operating Data:									Other Operating Data:
Number of revenue-generating professionals by segment (at period end)(5):
Number of revenue-generating professionals by segment (at period end):										Number of revenue-generating professionals by segment (at period end):
Healthcare	Healthcare		1,647				1,130			Healthcare		1,985			1,647
Education	Education		1,231				871			Education		1,633			1,231
Commercial (1)	Commercial (1)		1,145				1,115			Commercial (1)		1,395			1,145
Total	Total		4,023				3,116			Total		5,013			4,023

Revenue by capability:	Revenue by capability:									Revenue by capability:
Consulting and Managed Services (2)	Consulting and Managed Services (2)		$	150,584			$	122,551		Consulting and Managed Services (2)		$	177,194		$	150,584
Digital	Digital		109,465				80,662			Digital		140,701			109,465
Total	Total		$	260,049			$	203,213		Total		$	317,895		$	260,049

Number of revenue-generating professionals by capability (at period end):	Number of revenue-generating professionals by capability (at period end):									Number of revenue-generating professionals by capability (at period end):
Consulting and Managed Services (3)	Consulting and Managed Services (3)		2,003				1,376			Consulting and Managed Services (3)		2,360			2,003
Digital	Digital		2,020				1,740			Digital		2,653			2,020
Total	Total		4,023				3,116			Total		5,013			4,023

Utilization rate by capability(4):	Utilization rate by capability(4):									Utilization rate by capability (4):
Consulting	Consulting		71.4		%		66.4		%	Consulting		76.3		%	71.4		%
Digital	Digital		72.4		%		71.3		%	Digital		71.0		%	72.4		%

(1)The majority of our revenue-generating professionals within our Commercial segment can provide services across all of our industries, including healthcare and education.

(2)Managed Services capability ~~revenue~~revenues within our Healthcare segment was $19.8 million and $13.8 million for the three months ended March 31, ~~2022~~2023 and ~~March 31, 2021 was $13.8 million and $7.7 million,~~2022, respectively.

Managed Services capability ~~revenue~~revenues within our Education segment was $4.6 million and $3.4 million for the three months ended March 31, ~~2022~~2023 and ~~March 31, 2021 was $3.4 million and $2.2 million,~~2022, respectively.

(3)The number of Managed Services revenue-generating professionals within our Healthcare segment as of March 31, 2023 and 2022 was 726 and ~~March 31, 2021 was~~ 543, ~~and 114,~~ respectively.

The number of Managed Services revenue-generating professionals within our Education segment as of March 31, 2023 and 2022 was 101 and ~~March 31, 2021 was~~ 92, ~~and 52,~~ respectively.

(4)Utilization rates are presented for our revenue-generating professionals who primarily bill on an hourly basis. We do not present utilization rates for our Managed Services professionals as most of the revenues generated by these employees are not billed on an hourly basis.

~~(5)~~
During the first quarter of 2022, we reclassified certain Digital revenue-generating professionals within our Healthcare and Education segments to our Commercial segment as these professionals can provide services across all of our industries. This reclassification did not impact the total headcount within our Digital capability for any period. The prior period headcount has been revised for consistent presentation.

The number of revenue-generating professionals within our Healthcare segment at December 31, 2020, March 31, 2021, June 30, 2021, September 30, 2021 and December 31, 2021 were 1,117; 1,130; 1,443; 1,575; and 1,596, respectively.

2724

Table of Contents

The number of revenue-generating professional within our Education segment at December 31, 2020, March 31, 2021, June 30, 2021, September 30, 2021 and December 31, 2021 were 873; 871; 885; 958; and 1,050, respectively.

The number of revenue-generating professional within our Commercial segment at December 31, 2020, March 31, 2021, June 30, 2021, September 30, 2021 and December 31, 2021 were 1,059; 1,115; 1,131; 1,191; and 1,130, respectively.

Non-GAAP Measures

Three Months Ended
March 31,
2022 2021
Revenues $ 260,049 $ 203,213
Net income $ 26,852 $ 5,405
Add back:
Income tax expense 11,275 1,536
Interest expense, net of interest income 2,196 1,719
Depreciation and amortization 7,122 6,551
Earnings before interest, taxes, depreciation and amortization (EBITDA) 47,445 15,211
Add back:
Restructuring charges 1,555 628
Other losses 12 42
Transaction-related expenses 50 170
Unrealized gain on preferred stock investment (26,964) —
Foreign currency transaction losses, net 19 403
Adjusted EBITDA $ 22,117 $ 16,454
Adjusted EBITDA as a percentage of revenues 8.5 % 8.1 %
Reconciliation of Net Income to EBITDA and Adjusted EBITDA

Three Months Ended
March 31,
2022 2021
Net income $ 26,852 $ 5,405
Weighted average shares - diluted 21,167 22,341
Diluted earnings per share $ 1.27 $ 0.24
Add back:
Amortization of intangible assets 2,860 2,399
Restructuring and other charges 1,555 628
Other losses 12 42
Transaction-related expenses 50 170
Unrealized gain on preferred stock investment (26,964) —
Tax effect of adjustments 5,959 (858)
Total adjustments, net of tax (16,528) 2,381
Adjusted net income $ 10,324 $ 7,786
Adjusted weighted average shares - diluted 21,167 22,341
Adjusted diluted earnings per share $ 0.49 $ 0.35


	Three Months Ended March 31,
		2023			2022
Revenues		$	317,895		$	260,049
Net income		$	13,419		$	26,852
Add back:
Income tax expense		2,428			11,275
Interest expense, net of interest income		4,303			2,196
Depreciation and amortization		6,553			7,122
Earnings before interest, taxes, depreciation and amortization (EBITDA)		26,703			47,445
Add back:
Restructuring charges		2,284			1,555
Other losses		435			12


Transaction-related expenses		—			50
Unrealized gain on preferred stock investment		—			(26,964)
Foreign currency transaction losses, net		80			19
Adjusted EBITDA		$	29,502		$	22,117
Adjusted EBITDA as a percentage of revenues		9.3		%	8.5		%

Reconciliation of Net Income to Adjusted Net Income and Adjusted Diluted Earnings per Share


	Three Months Ended March 31,
		2023		2022
Net income		$	13,419	$	26,852
Weighted average shares - diluted		19,699		21,167
Diluted earnings per share		$	0.68	$	1.27
Add back:
Amortization of intangible assets		2,231		2,860
Restructuring charges		2,284		1,555
Other losses		435		12


Transaction-related expenses		—		50
Unrealized gain on preferred stock investment		—		(26,964)
Tax effect of adjustments		(1,312)		5,959


Total adjustments, net of tax		3,638		(16,528)
Adjusted net income		$	17,057	$	10,324
Adjusted weighted average shares - diluted		19,699		21,167
Adjusted diluted earnings per share		$	0.87	$	0.49

2825

Table of Contents

Three Months Ended March 31, ~~2022~~2023 Compared to Three Months Ended March 31, ~~2021~~2022

Revenues

Revenues by segment and capability for the three months ended March 31, ~~2022~~2023 and ~~2021~~2022 were as follows:


Revenues (in thousands)	Revenues (in thousands)	Three Months Ended March 31,				Percent Increase (Decrease)		Revenues (in thousands)	Three Months Ended March 31,				Increase / (Decrease)
		2022		2021					2023		2022		$		%
Segment:	Segment:							Segment:
Healthcare	Healthcare	$	121,876	$	95,975	27.0	%	Healthcare	$	149,049	$	121,876	$	27,173	22.3	%
Education	Education	80,662		51,342		57.1	%	Education	104,147		80,662		23,485		29.1	%
Commercial	Commercial	57,511		55,896		2.9	%	Commercial	64,699		57,511		7,188		12.5	%
Total revenues	Total revenues	$	260,049	$	203,213	28.0	%	Total revenues	$	317,895	$	260,049	$	57,846	22.2	%

Capability:	Capability:							Capability:
Consulting and Managed Services	Consulting and Managed Services	$	150,584	$	122,551	22.9	%	Consulting and Managed Services	$	177,194	$	150,584	$	26,610	17.7	%
Digital	Digital	109,465		80,662		35.7	%	Digital	140,701		109,465		31,236		28.5	%
Total revenues	Total revenues	$	260,049	$	203,213	28.0	%	Total revenues	$	317,895	$	260,049	$	57,846	22.2	%

Revenues increased ~~$56.8~~$57.8 million, or ~~28.0%~~22.2%, to $317.9 million for the first quarter of 2023 from $260.0 million for the first quarter of ~~2022 from $203.2 million for the first quarter of 2021.~~2022. The overall increase in revenues reflects continued strength in demand for our Digital capability services across all segments; as well as strengthened demand for ~~services in all of~~ our ~~segments, as well as the favorable comparison against results for the first quarter of 2021 in~~Consulting and Managed Services offerings within our Healthcare and Education segments, which ~~were more significantly impacted by the COVID-19 pandemic as some clients reprioritized~~reflects our focus on accelerating growth in our healthcare and ~~delayed certain projects as a result of the uncertainties surrounding the pandemic.~~education industries. Additional information on our revenues by segment follows.

•Healthcare revenues increased ~~$25.9~~$27.2 million, or ~~27.0%~~22.3%, driven by strengthened demand for our performance improvement, ~~and~~ revenue cycle managed services and business advisory solutions within our Consulting and Managed Services capability, as well as strengthened demand for our technology and analytics services within our Digital capability. Revenues in the first quarter of ~~2022~~2023 included ~~$0.6~~$0.3 million of incremental revenues from our acquisition of ~~Perception Health, Inc.,~~Customer Evolution, LLC, which was completed in December ~~2021.~~2022.

The number of revenue-generating professionals within our Healthcare segment grew ~~45.8%~~20.5% to 1,985 as of March 31, 2023, compared to 1,647 as of March 31, ~~2022, compared to 1,130 as of March 31, 2021, including an increase of 429 revenue-generating professionals within our Managed Services capability.~~2022.

•Education revenues increased ~~$29.3~~$23.5 million, or ~~57.1%~~29.1%, driven by strengthened demand for our ~~research, strategy~~technology and ~~operations,~~analytics services and ~~student solutions~~software products within our ~~Consulting and Managed Services~~Digital capability, as well as strengthened demand for our ~~technology~~strategy and ~~analytics services~~operations and research solutions within our ~~Digital~~Consulting and Managed Services capability. ~~Revenues in the first quarter of 2022 included $2.3 million of incremental revenues from our acquisition of Whiteboard Communications Ltd., which was completed in December 2021.~~

The number of revenue-generating professionals within our Education segment grew ~~41.3%~~32.7% to 1,633 as of March 31, 2023, compared to 1,231 as of March 31, ~~2022, compared to 871 as of March 31, 2021.~~2022.

•Commercial revenues increased ~~$1.6~~$7.2 million, or ~~2.9%~~12.5%, driven by strengthened demand for our technology and analytics services within our Digital capability and our restructuring and turnaround solution within our Consulting and Managed Services capability, partially offset by a decrease in ~~revenues due to the divestiture of our Life Sciences business in the fourth quarter of 2021 as well as a decrease in~~ demand for our ~~financial advisory solutions~~strategy and innovation solution within ~~the~~our Consulting and Managed Services capability. The Life Sciences business generated $4.7 million of revenues in the first quarter of 2021. Revenues in the first quarter of 2022 included $1.0 million of incremental revenues from our acquisitions of Unico Solution, Inc. and AIMDATA, LLC, which were completed in February 2021 and January 2022, respectively.

The number of revenue-generating professionals within our Commercial segment grew ~~2.7%~~21.8% to 1,395 as of March 31, 2023, compared to 1,145 as of March 31, 2022, compared to 1,115 as of March 31, 2021. This increase includes the impact of the divestiture of our Life Sciences business, which employed 73 revenue-generating professionals as of March 31, 2021.2022.

2926

Table of Contents

Operating Expenses

Operating expenses for the first quarter of ~~2022~~2023 increased ~~$51.9~~$59.1 million, or ~~26.4%~~23.8%, over the first quarter of ~~2021.~~2022.

Operating expenses and operating expenses as a percentage of revenues were as follows:


Operating Expenses (in thousands, except amounts as a percentage of revenues)	Operating Expenses (in thousands, except amounts as a percentage of revenues)	Three Months Ended March 31,						Increase / (Decrease)		Operating Expenses (in thousands, except amounts as a percentage of revenues)	Three Months Ended March 31,						Increase / (Decrease)
		2022			2021						2023			2022
Direct costs	Direct costs	$	187,247	72.0%	$	148,115	72.9%	$	39,132	Direct costs	$	228,383	71.9%	$	187,247	72.0%	$	41,136
Reimbursable expenses	Reimbursable expenses	4,756		1.8%	2,003		1.0%	2,753		Reimbursable expenses	8,624		2.7%	4,756		1.8%	3,868
Selling, general and administrative expenses	Selling, general and administrative expenses	48,395		18.6%	39,808		19.6%	8,587		Selling, general and administrative expenses	62,289		19.6%	48,395		18.6%	13,894
Restructuring charges	Restructuring charges	1,555		0.6%	628		0.3%	927		Restructuring charges	2,284		0.7%	1,555		0.6%	729
Depreciation and amortization	Depreciation and amortization	6,864		2.7%	6,353		3.1%	511		Depreciation and amortization	6,374		2.0%	6,864		2.7%	(490)
Total operating expenses	Total operating expenses	$	248,817	95.7%	$	196,907	96.9%	$	51,910	Total operating expenses	$	307,954	96.9%	$	248,817	95.7%	$	59,137

Direct Costs

Direct costs increased ~~$39.1~~$41.1 million, or ~~26.4%~~22.0%, to $228.4 million for the first quarter of 2023 from $187.2 million for the ~~three months ended March 31, 2022 from $148.1 million for the three months ended March 31, 2021.~~first quarter of 2022. The ~~$39.1~~$41.1 million increase primarily related to a ~~$33.0~~$35.3 million increase in ~~payroll~~compensation costs for our revenue-generating professionals as we continue to invest in and grow our talented team to meet increased market demand. Specifically, the increase in compensation costs is driven by increased headcount, annual salary increases that went into effect in the first quarter of ~~2022,~~2023, and ~~an increase~~increases in performance bonus ~~expense; as well as~~expense and share-based compensation expense. Additional increases in direct costs include a ~~$4.6~~$2.7 million increase in contractor ~~expense~~expenses and a ~~$1.5~~$1.2 million increase in technology costs. As a percentage of revenues, direct costs decreased to 71.8% during the first quarter of 2023, compared to 72.0% during the first quarter of 2022, ~~compared to 72.9% during the first quarter of 2021,~~ primarily due to revenue growth that outpaced the increase in ~~payroll~~compensation costs for our revenue-generating ~~professionals,~~professionals; partially offset by the increase in contractor ~~expense,~~expenses, as ~~a percentage~~percentages of revenues.

Reimbursable Expenses

Reimbursable expenses are billed to clients at cost and primarily relate to travel and out-of-pocket expenses incurred in connection with client engagements. These expenses are also included in total revenues and reimbursable expenses. We manage our business on the basis of revenues before reimbursable expenses, which we believe is the most accurate reflection of our services because it eliminates the effect of reimbursable expenses that are also included as a component of operating expenses.

Selling, General and Administrative Expenses

Selling, general and administrative expenses increased by ~~$8.6~~$13.9 million, or ~~21.6%~~28.7%, to $62.3 million in the first quarter of 2023 from $48.4 million in the first quarter of ~~2022 from $39.8 million in the first quarter of 2021.~~2022. The ~~$8.6~~$13.9 million increase primarily related to ~~a $5.1~~an $8.6 million increase in ~~payroll~~compensation costs for our support personnel, driven by ana $4.3 million increase in headcount, annual salary increases that went into effect in the first quarter of 2022, and increases in performance bonus expense and share-based compensation expense, partially offset by a $3.4 million decrease in deferred compensation expense attributable to the change in ~~the~~ market value of our deferred compensation ~~liability.~~liability, a $1.9 million increase in salaries and related expenses and a $1.6 million increase in share-based compensation expense. The ~~decrease~~increase in deferred compensation expense is ~~fully~~ offset by ~~a decrease~~an increase in the gain recognized for the change in the market value of investments that are used to fund our deferred compensation liability and recognized in other income, ~~(expense),~~ net. ~~The overall increase in~~Additionally, selling, general and administrative expenses ~~also includes~~increased by $5.3 million for non-payroll costs, driven by a ~~$3.5~~$2.0 million increase in ~~non-payroll costs which includes a $0.9 million increase in software~~practice administration and ~~data hosting~~meetings expenses, a ~~$0.9 million increase in legal fees, and a $0.8~~$2.0 million increase in promotion and marketing ~~expenses. These increases to non-payroll costs were partially offset by~~expenses, and a $1.0 million gain recognized ~~on the sale of our aircraft~~ in the first quarter of ~~2022.~~2022 related to the sale of our aircraft. As a percentage of revenues, selling, general and administrative expenses ~~decreased~~increased to 19.6% during the first quarter of 2023, compared to 18.6% during the first quarter of ~~2022, compared to 19.6% during the first quarter of 2021.~~2022. This ~~decrease~~increase was primarily attributable to the ~~decrease~~increases in deferred compensation expense and practice administration and meetings expenses, as percentages of revenues; partially offset by revenue growth that outpaced the increase in ~~the first quarter of 2022 compared to the first quarter of 2021.~~salaries and related expenses for our support personnel.

Restructuring Charges

Restructuring charges for the first quarter of ~~2022~~2023 were ~~$1.6~~$2.3 million, compared to ~~$0.6~~$1.6 million for the first quarter of ~~2021.~~ 2022. In the first quarter of 2023, we exited our office space in Hillsboro, Oregon which resulted in a $1.9 million non-cash impairment charge on the related fixed assets and right-of-use operating lease asset of that office space. Additionally, in the first quarter of 2023, we recognized $0.4 million of additional restructuring expense for rent and related expenses, net of sublease income, for previously vacated office spaces.

The $1.6 million of restructuring charges incurred in the first quarter of 2022 included $0.6 million for rent and related expenses, net of sublease income, for previously vacated office spaces, $0.5 million of employee-related expenses, $0.3 million of accelerated amortization of capitalized software implementation costs for a cloud-computing arrangement that is no longer in use, and $0.1 million for third-party transaction expenses related to the modification of our operating model. The $0.6 million of restructuring charges incurred in the first quarter of 2021 primarily related to rent and related expenses, net of sublease income, and accelerated depreciation on furniture and fixtures for vacated office spaces.

3027

Table of Contents

Depreciation and Amortization

Depreciation and amortization expense ~~which includes amortization of intangible assets and software development costs previously presented separately, increased~~decreased $0.5 million, or ~~8.0%~~7.1%, to $6.4 million in the first quarter of 2023, compared to $6.9 million ~~for~~in the ~~three months ended March 31, 2022, compared to $6.4 million for the three months ended March 31, 2021.~~first quarter of 2022. The $0.5 million ~~increase~~decrease in depreciation and amortization expense was primarily attributable to ~~an increase~~a decrease in amortization of intangible assets acquired in business acquisitions ~~completed subsequent~~due to the ~~first quarter~~accelerated basis of ~~2021.~~amortization in prior periods.

Operating Income and Operating Margin

Operating income increased ~~$7.7~~$2.5 million, or 15.5%, to $18.4 million in the first quarter of 2023 from $16.0 million in the first quarter of ~~2022 from $8.2 million in the first quarter of 2021.~~2022. Operating margin, which is defined as operating income expressed as a percentage of revenues, ~~increased~~decreased to 5.8% for the three months ended March 31, 2023, compared to 6.1% for the three months ended March 31, ~~2022, compared to 4.1% for the three months ended March 31, 2021.~~2022.

Operating income and operating margin for each of our segments is as follows. See the Segment and Consolidated Operating Results table above for a reconciliation of our total segment operating income to consolidated Huron operating income.


Segment Operating Income (in thousands, except operating margin percentages)	Segment Operating Income (in thousands, except operating margin percentages)	Three Months Ended March 31,								Increase / (Decrease)		Segment Operating Income (in thousands, except operating margin percentages)	Three Months Ended March 31,						Increase / (Decrease)
		2022				2021							2023			2022
Healthcare	Healthcare	$	28,032	23.0	%	$	23,827	24.8	%	$	4,205	Healthcare	$	32,255	21.6%	$	28,032	23.0%	$	4,223
Education	Education	14,306		17.7	%	8,537		16.6	%	5,769		Education	23,165		22.2%	14,306		17.7%	8,859
Commercial	Commercial	12,214		21.2	%	9,850		17.6	%	2,364		Commercial	14,067		21.7%	12,214		21.2%	1,853
Total segment operating income	Total segment operating income	$	54,552			$	42,214			$	12,338	Total segment operating income	$	69,487		$	54,552		$	14,935

•Healthcare operating income increased primarily due to the increase in revenues, partially offset by ~~an increase~~increases in ~~payroll~~compensation costs for our revenue-generating ~~professionals.~~professionals and contractor expenses. The increase in ~~payroll~~compensation costs was primarily driven by an increase in headcount, annual salary increases that went into effect in the first quarter of ~~2022,~~2023, and ~~an increase~~increases in performance bonus expense and share-based compensation expense. Healthcare operating margin decreased primarily due to the ~~increased payroll~~increase in contractor expenses, as a percentage of revenues; partially offset by revenue growth that outpaced the increase in compensation costs for our revenue-generating ~~professionals, as a percentage of revenues.~~professionals.

•Education operating income increased primarily due to the increase in revenues as well as a decrease in contractor expenses, partially offset by ~~an increase~~increases in ~~payroll~~compensation costs for our revenue-generating professionals, technology expenses, and ~~an increase in contractor expense.~~promotion and marketing expenses. The increase in ~~payroll~~compensation costs was primarily driven by an increase in headcount, annual salary increases that went into effect in the first quarter of ~~2022,~~2023, and an increase in performance bonus expense. Education operating margin increased ~~due to~~primarily driven by the decrease in contractor expenses and revenue growth that outpaced the increase in ~~payroll~~compensation costs ~~partially offset by the increase in contractor expenses, as a percentage of revenues.~~for our revenue-generating professionals.

•Commercial operating income increased primarily due to the increase in revenues, as well as decreases in compensation costs for our support personnel and ~~a decrease~~restructuring charges; partially offset by increases in ~~payroll~~compensation costs for our revenue-generating professionals ~~partially offset by an~~and promotion and marketing expenses. The increase in ~~contractor expense. The decrease in payroll~~compensation costs for our revenue-generating professionals was primarily driven by ~~the divestiture of our Life Sciences business~~an increase in headcount, annual salary increases that went into effect in the ~~fourth~~first quarter of ~~2021, partially offset by~~2023, and an increase in performance bonus expense. Commercial operating margin increased primarily due to the ~~decrease~~decreases in ~~payroll costs for our revenue-generating professionals, partially offset by increases in contractor expense and payroll~~compensation costs for our support personnel and restructuring charges; partially offset by the increase in promotion and marketing expenses, as ~~percentages~~a percentage of revenues.

Other Income (Expense), Net

Interest expense, net of interest income increased ~~$0.5~~$2.1 million to $4.3 million in the first quarter of 2023 from $2.2 million in the first quarter of 2022 ~~from $1.7 million in the first quarter of 2021~~ primarily attributable to higher levels of borrowing under our credit facility and higher interest rates during the first quarter of ~~2022~~2023 compared to the first quarter of ~~2021.~~2022. See “Liquidity and Capital Resources” below and Note 76 “Financing Arrangements” within the notes to our consolidated financial statements for additional information about our senior secured credit facility.

Other income, net ~~increased $23.9~~decreased $22.6 million to $1.7 million in the first quarter of 2023 from $24.4 million in the first quarter of ~~2022 from $0.4 million in the first quarter of 2021.~~2022. The ~~increase~~decrease in other income, net was primarily attributable to a $27.0 million unrealized gain recognized in the first quarter of 2022 related to the increase in the fair value of our preferred stock investment in Medically Home. See Note 109 “Fair Value of Financial Instruments” within the notes to our consolidated financial statements for additional information on our preferred stock investment in Medically Home. This ~~increase~~decrease in other income, net was partially offset by ~~the $3.4~~a $4.4 million ~~decrease~~increase in the gain recognized for the market value of our investments that are used to fund our deferred compensation liability. During the first quarter of ~~2022,~~2023, we recognized a ~~$2.6~~$1.8 million ~~loss~~gain for the market value of our deferred compensation investments compared to a ~~$0.8~~$2.6 million ~~gain~~loss recognized in the first quarter of ~~2021.~~2022.

Table of Contents

Income Tax Expense

~~Table of Contents~~

tax expense related to nondeductible losses on our investments used to fund our deferred compensation liability and certain nondeductible expense items.

For the three months ended March 31, 2021, our effective tax rate was 22.1% as we recognized income tax expense of $1.5 million on income of $6.9 million. The effective tax rate of 22.1% was more favorable than the statutory rate, inclusive of state income taxes, of 26.6%, primarily due to a discrete tax benefit for share-based c~~ompensation awards that vested during the first quarter of 2021.~~ ~~This favorable item was partially offset by certain nondeductible expense items.~~

Net Income ~~from Continuing Operations~~ and Earnings per Share

Net income ~~increased $21.4~~decreased $13.4 million to ~~$26.9~~$13.4 million for the three months ended March 31, ~~2022~~2023 from ~~$5.4~~$26.9 million for the same period last ~~year. The~~year, driven by the $27.0 million unrealized gain recognized in the first quarter of 2022 related to the increase in fair value of our preferred stock investment. As a result of the decrease in net income, diluted earnings per share for the first quarter of 2023 was $0.68 compared to $1.27 for the first quarter of 2022.

EBITDA and Adjusted EBITDA

EBITDA decreased $20.7 million to $26.7 million for the first quarter of 2023 from $47.4 million for the first quarter of 2022. The decrease in EBITDA was primarily attributable to ~~a $19.8~~the $27.0 million unrealized gain ~~net~~recognized in the first quarter of ~~tax,~~2022 related to the increase in the fair value of our preferred stock ~~investment in Medically Home. As a result of the increase in net income, diluted earnings per share for the first quarter of 2022 was $1.27 compared to $0.24 for the first quarter of 2021.~~

~~EBITDA and Adjusted EBITDA~~

EBITDA increased $32.2 million to $47.4 million for the three months ended March 31, 2022 from $15.2 million for the three months ended March 31, 2021. The increase in EBITDA was primarily attributable to the $27.0 million unrealized gain related to the increase in the fair value of our preferred stock investmentinvestment; as well as the increase in ~~segment operating income,~~corporate expenses, excluding the impact of the change in the market value of our deferred compensation liability. These decreases to EBITDA were partially offset by anthe increase in ~~corporate expenses.~~segment operating income.

Adjusted EBITDA increased ~~$5.7~~$7.4 million to $29.5 million in the first quarter of 2023 from $22.1 million in the first quarter of ~~2022 from $16.5 million in the first quarter of 2021.~~2022. The increase in adjusted EBITDA was primarily attributable to the increase in segment operating income, excluding the impact of segment restructuring charges; partially offset by anthe increase in corporate expenses, excluding the ~~impact~~impacts of the change in the market value of our deferred compensation liability and corporate restructuring ~~charges on these items.~~charges.

Adjusted Net Income ~~from Continuing Operations~~ and Adjusted Earnings per Share

Adjusted net income increased ~~$2.5~~$6.7 million to $17.1 million in the first quarter of 2023 compared to $10.3 million in the first quarter of ~~2022 compared to $7.8 million in the first quarter of 2021.~~2022. As a result of the increase in adjusted net income, adjusted diluted earnings per share was $0.87 for the first quarter of 2023, compared to $0.49 for the first quarter of ~~2022, compared to $0.35 for the first quarter of 2021.~~2022.

LIQUIDITY AND CAPITAL RESOURCES

Cash and cash equivalents were ~~$9.7~~$12.0 million and ~~$20.8~~$11.8 million at March 31, ~~2022~~2023 and December 31, ~~2021.~~2022, respectively. As of March 31, ~~2022,~~2023, our primary sources of liquidity are cash on hand, cash flows from our U.S. operations, and borrowing capacity available under our credit facility.


		Three Months Ended March 31,					Three Months Ended March 31,
Cash Flows (in thousands):	Cash Flows (in thousands):	2022		2021		Cash Flows (in thousands):	2023		2022
Net cash used in operating activities	Net cash used in operating activities	$	(79,099)	$	(82,754)	Net cash used in operating activities	$	(92,101)	$	(79,099)
Net cash used in investing activities	Net cash used in investing activities	(3,316)		(8,037)		Net cash used in investing activities	(10,172)		(3,316)
Net cash provided by financing activities	Net cash provided by financing activities	71,387		45,082		Net cash provided by financing activities	102,449		71,387
Effect of exchange rate changes on cash	Effect of exchange rate changes on cash	(5)		155		Effect of exchange rate changes on cash	16		(5)
Net decrease in cash and cash equivalents		$	(11,033)	$	(45,554)
Net increase (decrease) in cash and cash equivalents						Net increase (decrease) in cash and cash equivalents	$	192	$	(11,033)

Operating Activities

Our operating assets and liabilities consist primarily of receivables from billed and unbilled services, accounts payable and accrued expenses, accrued payroll and related benefits, operating lease obligations and deferred revenues. The volume of services rendered and the related billings and timing of collections on those billings, as well as payments of our accounts payable and salaries, bonuses, and related benefits to employees affect these account balances. Our purchase obligations primarily consist of payments for software and other information technology products to support our business and corporate infrastructure.

Net cash used in operating activities ~~decreased $3.7~~increased $13.0 million to $92.1 million for the three months ended March 31, 2023 from $79.1 million for the three months ended March 31, ~~2022 from $82.8 million for the three months ended March 31, 2021.~~2022. The ~~decrease~~increase in net cash used in operating activities was primarily related to ~~an increase in cash collections in the first three months of 2022 compared to the same prior year period, largely offset by an increase in salaries and related expenses for our employees and~~ an increase in the amount paid for annual performance bonuses in the first quarter of ~~2022~~2023 compared to the first quarter of ~~2021.~~2022, an increase in salaries and related expenses for our

Table of Contents

revenue-generating professionals, and increases in payments for selling, general and administrative expenses for the first three months of 2023 compared to the same prior year period; largely offset by an increase in cash collections in the first three months of 2023 compared to the same prior year period.

Additionally, in the first quarter of 2023, our unbilled receivables increased, partially driven by certain large Healthcare and Education engagements where our services performed and revenue recognized exceeded the amounts billed to clients in accordance with the contractual billing terms. We expect to bill and collect for these services in the second half of 2023. In the future, we may enter into additional client engagements with similar deferred billing terms.

Investing Activities

Our investing activities primarily consist of purchases of complementary businesses; purchases of property and equipment, primarily related to computers and related equipment for our employees and leasehold improvements and furniture and fixtures for office spaces; payments related to internally

~~Table of Contents~~

developed cloud-based software sold to our clients; and investments. Our investments include a convertible note investment in Shorelight Holdings, LLC, a preferred stock investment in Medically Home Group, Inc., and investments in life insurance policies that are used to fund our deferred compensation liability.

The use of cash in the first three months of ~~2022~~2023 primarily consisted of $6.6 million for payments related to internally developed software to advance our Healthcare and Education software products; $2.0 million for purchases of property and equipment, primarily related to purchases of computers and related equipment; and $1.8 million for contributions to our life insurance policies.

The use of cash in the first three months of 2022 included $3.9 million for purchases of property and equipment, primarily related to purchases of leasehold improvements and furniture for certain office spaces and computers and related equipment; $2.3 million for the purchase of a ~~business;~~business and $2.1 million for payments related to internally developed software. These uses of cash for investing activities were partially offset by $4.8 million of cash received for the sale of our aircraft in the first quarter of 2022.

The use of cash in the first three months of 2021 primarily consisted of $6.0 million for the purchase of a business; $1.4 million for payments related to internally developed software; and $0.6 million for purchases of property and equipment, primarily related to purchases of leasehold improvements for certain office spaces and computers and related equipment.

We estimate that cash utilized for purchases of property and equipment and software development in ~~2022~~2023 will total approximately ~~$20~~$30 million to ~~$25~~$35 million; primarily consisting of software development costs, information technology related equipment to support our corporate infrastructure, and leasehold improvements and furniture and fixtures for certain office ~~locations, and information technology related equipment to support our corporate infrastructure.~~locations.

Financing Activities

Our financing activities primarily consist of borrowings and repayments under our senior secured credit facility, share repurchases, shares redeemed for employee tax withholdings upon vesting of share-based compensation, and payments for contingent consideration liabilities related to business acquisitions. See “Financing Arrangements” below for additional information on our senior secured credit facility.

Net cash provided by financing activities ~~increased~~was $102.4 million for the three months ended March 31, 2023. During the three months ended March 31, 2023, we borrowed $201.0 million primarily to fund our operations, including our annual performance bonus payment in the first quarter of 2023, and made repayments on our borrowings of $44.0 million. Additionally, during the first three months of 2023, we paid $45.1 million for share repurchases, including $1.1 million related to the settlement of share repurchases that were accrued as of December 31, 2022, and reacquired $9.5 million of common stock as a result of tax withholdings upon vesting of share-based compensation.

Net cash provided by ~~$26.3 million to~~financing activities was $71.4 million for the three months ended March 31, ~~2022 from $45.1 million for the three months ended March 31, 2021.~~

2022. During the three months ended March 31, 2022, we borrowed $150.0 million under our credit facility primarily to fund our operations, including our annual performance bonus payment in the first quarter of 2022, and made repayments on our borrowings of $47.8 million. These repayments on our borrowings included the repayment of the outstanding principal of our promissory note due 2024 of $2.7 million from the proceeds received for the sale of our aircraft. Additionally, during the first three months of 2022, we repurchased and retired $23.9 million of our common stock under our share repurchase program, ~~discussed below,~~ and settled $0.2 million of share repurchases that were accrued as of December 31, 2021. We also reacquired $6.9 ~~million of common stock as a result of tax withholdings upon vesting of share-based compensation.~~

During the three months ended March 31, 2021, we borrowed $89.0 million primarily to fund our annual performance bonus payment and made repayments on our borrowings of $24.1 million. Additionally, during the first three months of 2021, we repurchased and retired $11.5 million of our common stock under our share repurchase program. We also reacquired $8.5 million of common stock as a result of tax withholdings upon vesting of share-based compensation.

Share Repurchase Program

In November 2020, our board of directors authorized a share repurchase program permitting us to repurchase up to $50 million of our common stock through December 31, 2021. ~~During~~Subsequent to the ~~third quarter of 2021,~~initial authorization, our board of directors authorized ~~an extension~~extensions of the share repurchase program ~~through December 31, 2022 and increased the authorized amount to $100 million. During the first quarter of 2022, our board of directors authorized a further extension~~ through December 31, 2023 and increased the authorized amount to ~~$200~~$300 million. The amount and timing of repurchases under the share repurchase program were and will continue to be determined by management and depend on a variety of factors, including the trading price of our common stock, capacity under our credit facility, general market and business conditions, and applicable legal requirements. As of March 31, ~~2022, $106.3~~2023, $64.8 million remained available for share repurchases under our share repurchase program.

Financing Arrangements

At March 31, ~~2022,~~2023, we had ~~$335.0~~$447.0 million outstanding under our senior secured credit facility, as discussed below.

Table of Contents

The Company has a $600 million five-year senior secured revolving credit facility, subject to the terms of a ~~Second~~Third Amended and Restated Credit Agreement dated as of ~~March 31, 2015, as amended to date (as amended and modified the~~November 15, 2022 (the "Amended Credit Agreement"), that becomes due and payable in full upon maturity on ~~September 27, 2024.~~November 15, 2027. The Amended Credit Agreement provides the option to increase the revolving credit facility or establish term loan facilities in an aggregate amount of up to ~~$150~~$250 million, subject to customary conditions and the approval of any lender whose commitment would be increased, resulting in a maximum available principal amount under the Amended Credit Agreement of ~~$750~~$850 million. ~~Borrowings~~The initial borrowings under the Amended Credit Agreement were used to refinance borrowings outstanding under a prior credit agreement, and future borrowings under the Amended Credit Agreement may be used for working capital, capital expenditures, ~~acquisitions of businesses,~~ share repurchases, permitted acquisitions, and other general corporate purposes.

~~Table of Contents~~

plus the applicable margin. The applicable margin will fluctuate between 1.125% per annum and 1.875% per annum, in the case of ~~LIBOR~~Term SOFR borrowings, or between 0.125% per annum and 0.875% per annum, in the case of base rate loans, based upon our Consolidated Leverage Ratio at such time. Fees and interest on borrowings isare paid on a monthly basis.

Amounts borrowed under the Amended Credit Agreement may be prepaid at any time without premium or penalty. We are required to prepay the amounts outstanding under the Amended Credit Agreement in certain ~~circumstances.~~circumstances, including upon an Event of Default (as defined in the Amended Credit Agreement). In addition, we have the right to permanently reduce or terminate the unused portion of the commitments provided under the Amended Credit Agreement at any time.

The Amended Credit Agreement contains usual and customary representations and warranties; affirmative and negative covenants, which include limitations on liens, investments, additional indebtedness, and restricted payments; and two quarterly financial covenants as follows: (i) a maximum Consolidated Leverage Ratio (defined as the ratio of debt to consolidated EBITDA) of 3.75 to 1.00; however the maximum permitted Consolidated Leverage Ratio will increase to ~~4.00~~4.25 to 1.00 upon the occurrence of ~~certain transactions,~~a Qualified Acquisition (as defined in the Amended Credit Agreement), and (ii) a minimum Consolidated Interest Coverage Ratio (defined as the ratio of consolidated EBITDA to interest) of ~~3.50~~3.00 to 1.00. Consolidated EBITDA for purposes of the financial covenants is calculated on a continuing operations basis and includes adjustments to add back non-cash goodwill impairment charges, share-based compensation costs, certain non-cash restructuring charges, pro forma historical EBITDA for businesses acquired, and other specified items in accordance with the Amended Credit Agreement. For purposes of the Consolidated Leverage Ratio, total debt is on a gross basis and is not netted against our cash balances. At March 31, ~~2022~~2023 and December 31, ~~2021,~~2022, we were in compliance with these financial covenants. Our Consolidated Leverage Ratio as of March 31, ~~2022~~2023 was ~~2.24~~2.75 to 1.00, compared to ~~1.73~~1.92 to 1.00 as of December 31, ~~2021.~~2022. Our Consolidated Interest Coverage Ratio as of March 31, ~~2022~~2023 was ~~19.08~~12.63 to 1.00, compared to ~~18.43~~14.04 to 1.00 as of December 31, ~~2021.~~2022.

The Amended Credit Agreement contains restricted payment provisions, including a potential limit on the amount of dividends we may pay. Pursuant to the terms of the Amended Credit Agreement, if our Consolidated Leverage Ratio is greater than ~~3.25,~~3.50, the amount of dividends and other Restricted Payments (as defined in the Amended Credit Agreement) we may pay is limited to an amount up to ~~$25~~$50 million.

Principal borrowings outstanding under the Amended Credit Agreement at March 31, ~~2022~~2023 and December 31, ~~2021~~2022 totaled ~~$335.0~~$447.0 million and ~~$230.0~~$290.0 million, respectively. These borrowings carried a weighted average interest rate of ~~2.1%~~4.8% at March 31, ~~2022~~2023 and ~~2.7%~~3.8% at December 31, ~~2021,~~2022, including the impact of the interest rate swaps described in Note 98 “Derivative Instruments and Hedging Activity” within the notes to the consolidated financial statements. The borrowing capacity under the revolving credit facility is reduced by any outstanding borrowings under the revolving credit facility and outstanding letters of credit. At March 31, ~~2022,~~2023, we had outstanding letters of credit totaling ~~$0.7~~$0.6 million, which are ~~primarily~~ used as security deposits for our office facilities. As of March 31, ~~2022,~~2023, the unused borrowing capacity under the revolving credit facility was ~~$264.3~~$152.4 million.

~~For further information, see Note 7 “Financing Arrangements” within the notes to the consolidated financial statements.~~

Future Financing Needs

~~Throughout 2021, our~~Our primary financing need ~~was~~is to support our operations and maintain our liquidity during the COVID-19 pandemic. As such, we took proactive measures to increase available cash on hand, including, but not limited to, borrowing under our senior secured credit facility, reducing discretionary operating and capital expenses, and electing to defer the deposit of our employer portion of social security taxes as provided for under the CARES Act.

~~Given improved visibility to our project backlog and access to capital resources, our primary financing need has returned to funding~~fund our long-term growth. Our growth strategy is to expand our service offerings, which may require investments in new hires, acquisitions of complementary businesses, possible expansion into other geographic areas, and related capital expenditures.

We believe our internally generated liquidity, together with our available cash, and the borrowing capacity available under our revolving credit facility will be adequate to support our current financing needs and long-term growth strategy. Our ability to secure additional financing ~~if needed,~~ in the future, if needed, will depend on several factors, including our future profitability, the quality of our accounts receivable and unbilled services, our relative levels of debt and equity, and the overall condition of the credit markets.

Table of Contents

OFF-BALANCE SHEET ARRANGEMENTS

We are not a party to any material off-balance sheet arrangements.

CRITICAL ACCOUNTING POLICIES

Management’s discussion and analysis of financial condition and results of operations is based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). We regularly review our financial reporting and disclosure practices and accounting policies to ensure that our financial reporting and disclosures provide accurate information relative to the current economic and business environment. The preparation of financial statements in conformity with GAAP requires management to make assessments, estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Critical accounting policies are those policies that we believe present the most complex or subjective measurements and have the

~~Table of Contents~~

most potential to impact our financial position and operating results. While all decisions regarding accounting policies are important, we believe there are five accounting policies that could be considered critical: revenue recognition, allowances for doubtful accounts and unbilled services, business combinations, carrying values of goodwill and other intangible assets, and accounting for income taxes. For a detailed discussion of these critical accounting policies, see Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting Policies” in our Annual Report on Form 10-K for the year ended December 31, ~~2021. Below is an update to our critical accounting policy related to the carrying values of goodwill and other intangible assets.~~2022. There have been no material changes to our ~~other~~ critical accounting policies during the ~~first~~ three months ~~of 2022.~~

~~Carrying Values of Goodwill and Other Intangible Assets~~

~~First Quarter 2022 Goodwill Reallocation~~

Effective January 1, 2022, we modified our operating model to expand and more deeply integrate our industry expertise with our digital, strategic and financial advisory capabilities. To align with the new operating model, effective with reporting for periods beginning January 1, 2022, we began reporting under the following three industries, which are our reportable segments: Healthcare, Education and Commercial. The Commercial segment includes all industries outside of healthcare and education, including, but not limited to, financial services and energy and utilities. In the new reporting structure, each segment includes all revenue and costs associated with engagements delivered in the respective segments' industries. The new Healthcare and Education segments include some revenue and costs historically reported in the Business Advisory segment and the Healthcare segment includes some revenue and costs historically reported in the Education segment.

The three reportable segments of Healthcare, Education and Commercial are also our reporting units for goodwill impairment testing purposes. As a result of the reorganization, we reallocated the goodwill balances of our historical reporting units to our new reporting units based on the relative estimated fair values of each component of the historical reporting units to be allocated to the new reporting units. Additionally, we performed a goodwill impairment test on the goodwill balances of each of our reporting units as of January 1, 2022 by comparing the fair value of the reporting unit to its carrying value, including the reallocated goodwill. Based on the results of the goodwill impairment test, we determined the fair values of the Healthcare, Education, and Commercial reporting units exceeded their carrying values by 37%, 199%, and 105%, respectively. As such, we concluded that there was no indication of goodwill impairment for all three reporting units as of January 1, 2022.

NEW ACCOUNTING PRONOUNCEMENTS

~~See Note 3 “New Accounting Pronouncements” within the notes~~No new accounting pronouncements or changes in accounting pronouncements have been issued or adopted that are material to ~~the~~our consolidated financial statements since those included in our Annual Report on Form 10-K for ~~information on new accounting pronouncements.~~the year ended December 31, 2022.


ITEM 3.			QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

We are exposed to market risks primarily from changes in interest rates and foreign currency exchange rates and changes in the market value of our investments. We use certain derivative instruments to hedge a portion of the interest rate and foreign currency exchange rate risks.

~~Market Risk and~~ Interest Rate Risk

We have exposure to changes in interest rates associated with borrowings under our bank credit facility, which ~~has~~have variable interest rates tied to ~~LIBOR~~Term SOFR or an alternate base rate, at our option. At March 31, ~~2022,~~2023, we had borrowings outstanding under the credit facility totaling ~~$335.0~~$447.0 million that carried a weighted average interest rate of ~~2.1%~~4.8%, including the impact of the interest rate swaps described below. A hypothetical 100 basis point change in the interest rate would have a ~~$1.4~~$2.0 million effect on our pretax income on an annualized basis, including the effect of the interest rate swaps. At December 31, ~~2021,~~2022, we had borrowings outstanding under the credit facility totaling ~~$230.0~~$290.0 million that carried a weighted average interest rate of ~~2.7%~~3.8% including the impact of the interest rate ~~swaps.~~swaps described below. A hypothetical 100 basis point change in the interest rate would have had a ~~$0.3~~$0.9 million effect on our pretax income on an annualized basis, including the effect of the interest rate swaps.

~~On June 22, 2017, we entered~~We enter into a forward interest rate swap ~~agreement effective August 31, 2017 and ending August 31, 2022, with a notional amount of $50.0 million. We entered into this derivative instrument~~agreements to hedge against the interest rate risks of our variable-rate borrowings. Under the terms of the interest rate swap agreement, we receive from the counterparty interest on the notional amount based on one-month ~~LIBOR~~Term SOFR and we pay to the counterparty a stated, fixed ~~rate~~rate. As of ~~1.900%.~~

~~On January 30, 2020, we entered into a~~March 31, 2023 and December 31, 2022, the aggregate notional amount of our forward interest rate swap ~~agreement effective~~agreements was $250.0 million and $200.0 million, respectively. The outstanding interest rate swap agreements as of March 31, 2023 are scheduled to mature on a staggered basis through February 29, 2028.

Foreign Currency Risk

We have exposure to changes in foreign currency exchange rates between the U.S. Dollar (USD) and the Indian Rupee (INR) related to our operations in India. We hedge a portion of our cash flow exposure related to our INR-denominated intercompany expenses by entering into non-deliverable foreign exchange forward contracts. As of March 31, 2023 and December 31, ~~2019~~2022, the aggregate notional amounts of these contracts were INR 789.6 million, or $9.6 million, and ~~ending~~INR 657.9 million, or $8.0 million, respectively, based on the exchange rates in effect as of each period end. The outstanding foreign exchange forward contracts as of March 31, 2023 are scheduled to mature monthly through December 29, 2023.

We use a sensitivity analysis to determine the effects that market foreign currency exchange rate fluctuations may have on the fair value of our foreign currency exchange rate hedge portfolio. The sensitivity of the hedge portfolio is computed based on the market value of future cash flows as affected by changes in exchange rates. This sensitivity analysis represents the hypothetical changes in value of the hedge position and does not reflect the offsetting gain or loss on the underlying exposure. A hypothetical 100 basis point change in the foreign currency exchange rate between the USD and INR would have an immaterial impact on the fair value of our hedge instruments as of March 31, 2023 and December 31, ~~2024, with a notional amount of $50.0 million. We entered into this derivative instrument to further hedge against the interest rate risks of our variable-rate~~2022.

3532

Table of Contents

borrowings. Under the terms of the interest rate swap agreement, we receive from the counterparty interest on the notional amount based on one month LIBOR and we pay to the counterparty a fixed rate of 1.500%.

In 2017, the Financial Conduct Authority (FCA) in the U.K. announced that it would phase out LIBOR as a benchmark rate by the end of 2021. In March 2021, the ICE Benchmark Administration Limited, the administrator of LIBOR, extended the transition dates of certain LIBOR tenors (including all U.S. Dollar LIBOR tenors other than one-week and two-month U.S. Dollar LIBOR tenors) to June 30, 2023, after which LIBOR reference rates will cease to be provided. Our Amended Credit Agreement and interest rate swap agreements provide for any transitions away from LIBOR to a successor rate to be based on prevailing or equivalent standards.

We have a 1.69% convertible debt investment in Shorelight Holdings, LLC, a privately-held company, which we account for as an available-for-sale debt security. As such, the investment is carried at fair value with unrealized holding gains and losses excluded from earnings and reported in other comprehensive income. As of March 31, ~~2022,~~2023, the fair value of the investment was ~~$62.3~~$62.8 million, with a total cost basis of $40.9 million. At December 31, ~~2021,~~2022, the fair value of the investment was ~~$65.9~~$57.6 million, with a total cost basis of $40.9 million.

We have a preferred stock investment in Medically Home Group, Inc. ("Medically Home"), a privately-held company, which we account for as an equity security without a readily determinable fair value using the measurement alternative. As such, the investment is carried at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment. Any unrealized holding gains and losses resulting from observable price changes are recorded in our consolidated statement of operations. As of March 31, 2023 and December 31, 2022, the carrying value of the investment was $33.6 ~~million, with a total cost basis of $5.0 million. As of December 31, 2021, the carrying value of the investment was $6.7~~ million with a total cost basis of $5.0 million. During the first quarter of 2022, we recognized an unrealized gain of $27.0 million on our preferred stock investment resulting from an observable price change of preferred stock with similar rights and preferences to our preferred stock investment issued by Medically Home. Following our purchase, we have not identified any impairment of our investment.

We do not use derivative instruments for trading or other speculative purposes. From time to time, we invest excess cash in short-term marketable securities. These investments principally consist of overnight sweep accounts. Due to the short maturity of these investments, we have concluded that we do not have material market risk exposure. Refer to Note 8 “Derivative Instruments and Hedging Activity” within the notes to our consolidated financial statements for additional information on our derivative instruments.


ITEM 4.			CONTROLS AND PROCEDURES.

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of March 31, ~~2022.~~2023. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that, as of March 31, ~~2022,~~2023, our disclosure controls and procedures were effective in recording, processing, summarizing and reporting, on a timely basis, information required to be disclosed by us in the reports we file or submit under the Exchange Act, and such information is accumulated and communicated to management as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

There has been no change in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the three months ended March 31, ~~2022~~2023 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II—OTHER INFORMATION


ITEM 1.			LEGAL PROCEEDINGS.

~~The information required by this item is incorporated by reference from Note 13 “Commitments, Contingencies and Guarantees” included in Part I, Item 1 of this Form 10-Q.~~

~~Table of Contents~~


ITEM 1A.			RISK FACTORS.

See Part 1, Item 1A, “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, ~~2021,~~2022, which was filed with the Securities and Exchange Commission on February ~~24, 2022,~~28, 2023, for a complete description of the material risks we face.


ITEM 2.			UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

On December 1, 2021, as partial consideration for our acquisition of Whiteboard Communications Ltd., we issued 74,671 shares of our common stock, par value $0.01 per share, with an aggregate value of $3.3 million. The issuance was exempt from registration under Section 4(a)(2) of the Securities Act of 1933, as amended, as a transaction by an issuer not involving a public offering.

Our Stock Ownership Participation Program ~~2012 Omnibus Incentive Plan,~~ and ~~2004 Omnibus Stock Plan, which was replaced by the~~ 2012 Omnibus Incentive Plan permit the netting of common stock upon vesting of restricted stock awards to satisfy individual tax withholding requirements. During the quarter ended March 31, ~~2022,~~2023, we reacquired ~~139,491~~135,420 shares of common stock with a weighted average fair market value of ~~$49.35~~$70.37 as a result of such tax withholdings.

Table of Contents

repurchase program were and will continue to be determined by management and depend on a variety of factors, including the trading price of our common stock, capacity under our credit facility, general market and business conditions, and applicable legal requirements.

The following table provides information with respect to purchases we made of our common stock during the quarter ended March 31, ~~2022.~~2023.

Period
Total Number of Shares Purchased (1)
Average Price
Paid per Share Total Number of
Shares Purchased
as Part of Publicly
Announced Plans
or Programs
Dollar Value of Shares
that may yet be
Purchased under the
Plans or Programs (2)
January 1 2022 - January 31, 2022 179,975 $ 46.29 169,656 $ 22,349,716
February 1, 2022 - February 28, 2022 353,751 $ 45.44 353,743 $ 6,266,001
March 1, 2022 - March 31, 2022 129,164 $ 49.31 — $ 106,266,001
Total 662,890 $ 46.42 523,399


Period	Total Number of Shares Purchased (1)	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Dollar Value of Shares that may yet be Purchased under the Plans or Programs (2)
January 1, 2023 - January 31, 2023	273,369	$	69.42	263,948	$	90,558,075
February 1, 2023 - February 28, 2023	368,946	$	69.69	368,946	$	64,836,694
March 1, 2023 - March 31, 2023	125,999	$	70.22	—	$	64,836,694
Total	768,314	$	69.68	632,894

(1)The number of shares repurchased included ~~10,319~~9,421 shares in January ~~2022, 8 shares in February 2022,~~2023 and ~~129,164~~125,999 shares in March ~~2022~~2023 to satisfy employee tax withholding requirements. These shares do not reduce the repurchase authority under the share repurchase program.

(2)As of the end of the period.


ITEM 3.			DEFAULTS UPON SENIOR SECURITIES.

None.


ITEM 4.			MINE SAFETY DISCLOSURES.

Not applicable.


ITEM 5.			OTHER INFORMATION.

None.

3734

Table of Contents


ITEM 6.			EXHIBITS.

(a) The following exhibits are filed as part of this Quarterly Report on Form 10-Q.

Incorporated by Reference

Exhibit
Number

Exhibit Description

Filed
herewith

Furnished
herewith

Form

Period
Ending

Exhibit

Filing
Date

10.1†

Amendment No. 1 to the Third Amended and Restated Credit Agreement, dated as of April 28, 2023, by and among Huron Consulting Group Inc., as Borrower, and PNC Capital Markets LLC, as Sustainability Structuring Agent for and on behalf of the Lenders.

8-K

10.1

5/2/2023

31.1

Certification of the Chief Executive Officer, pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2

Certification of the Chief Financial Officer, pursuant to Rule 13a-14(a)/15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1

Certification of the Chief Executive Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2

Certification of the Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS

Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

101.SCH

Inline XBRL Taxonomy Extension Schema Document

101.CAL

Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.LAB

Inline XBRL Taxonomy Extension Label Linkbase Document

101.PRE

Inline XBRL Taxonomy Extension Presentation Linkbase Document

101.DEF

Inline XBRL Taxonomy Extension Definition Linkbase Document

104

Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

†† Pursuant to Regulation S-K 601(b)(10)(iv), certain exhibits to this Exhibit have been omitted. The Company agrees to furnish supplementally to the Securities and Exchange Commission, upon its request, a copy of any or all omitted exhibits.

3835

Table of Contents

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Huron Consulting Group Inc.

(Registrant)

Date:

May ~~3, 2022~~2, 2023

/S~~/ JOHN~~ s/ JOHN D. KKELLY~~ELLY~~

John D. Kelly

Executive Vice President,
Chief Financial Officer and Treasurer

3936


		Page
Part I – Financial Information

Item 1.	Consolidated Financial Statements (Unaudited)
	Consolidated Balance Sheets	1
	Consolidated Statements of Operations and Other Comprehensive Income	2
	Consolidated Statements of Stockholders’ Equity	3
	Consolidated Statements of Cash Flows	4
	Notes to Consolidated Financial Statements	5

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	2118

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	3532

Item 4.	Controls and Procedures	3633

Part II – Other Information

Item 1.	Legal Proceedings	3633

Item 1A.	Risk Factors	3733

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	3733

Item 3.	Defaults Upon Senior Securities	3734

Item 4.	Mine Safety Disclosures	3734

Item 5.	Other Information	3734

Item 6.	Exhibits	3835

Signature		3936


	Healthcare		Education		Commercial(1)		Total
Balance as of December 31, 2021:
Goodwill	$	642,951	$	121,570	$	312,250	$	1,076,771
Accumulated impairment losses	(208,081)		—		(247,811)		(455,892)
Goodwill, net as of December 31, 2021	434,870		121,570		64,439		620,879
Goodwill reallocation(1)	18,057		(1,417)		(16,640)		—
Goodwill recorded in connection with business acquisitions (2)(3)	162		2,082		718		2,962

Goodwill, net as of March 31, 2022	$	453,089	$	122,235	$	48,517	$	623,841


Year Ending December 31,	Estimated Amortization Expense(1)
2022	$	11,198
2023	$	7,904
2024	$	4,514
2025	$	3,386
2026	$	2,435


	Fair Value (Derivative Asset and Liability)
Balance Sheet Location	March 31, 2022		December 31, 2021
Prepaid expenses and other current assets	$	1,019	$	—
Other non-current assets	$	4,501	$	1,210
Accrued expenses and other current liabilities	$	183	$	1,604
Deferred compensation and other liabilities	$	—	$	149


	Three Months Ended March 31, 2022						Three Months Ended March 31, 2021
	Before Taxes		Tax (Expense) Benefit		Net of Taxes		Before Taxes		Tax (Expense) Benefit		Net of Taxes
Other comprehensive income (loss):
Foreign currency translation adjustments	$	(43)	$	—	$	(43)	$	400	$	—	$	400
Unrealized gain (loss) on investment	$	(3,617)	$	956	$	(2,661)	$	(6,328)	$	1,680	$	(4,648)
Unrealized gain (loss) on cash flow hedges:
Change in fair value	$	5,668	$	(1,499)	$	4,169	$	1,189	$	(337)	$	852
Reclassification adjustments into earnings	212		(56)		156		780		(203)		577
Net unrealized gain (loss)	$	5,880	$	(1,555)	$	4,325	$	1,969	$	(540)	$	1,429
Other comprehensive income (loss)	$	2,220	$	(599)	$	1,621	$	(3,959)	$	1,140	$	(2,819)


	Foreign Currency Translation		Available-for-Sale Investment		Cash Flow Hedges		Total
Balance, December 31, 2021	$	(1,143)	$	18,374	$	(391)	$	16,840
Current period change	(43)		(2,661)		4,325		1,621
Balance, March 31, 2022	$	(1,186)	$	15,713	$	3,934	$	18,461


	Three Months Ended March 31, 2022
	Healthcare		Education		Commercial		Total
Capability
Consulting and Managed Services	$	83,759	$	44,181	$	22,644	$	150,584
Digital	38,117		36,481		34,867		109,465
Total	$	121,876	$	80,662	$	57,511	$	260,049


	Three Months Ended March 31, 2021
	Healthcare		Education		Commercial		Total
Capability
Consulting and Managed Services	$	66,929	$	28,033	$	27,589	$	122,551
Digital	29,046		23,309		28,307		80,662
Total	$	95,975	$	51,342	$	55,896	$	203,213